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Introduction
For forty years, the United States government allowed economically
disadvantaged 1 African American men to be exploited in the name of
research, although the research could not generate any benefit to society. 2 Specifically, from 1932 until 1972, government funded researchers enrolled economically disadvantaged African American men in the
Tuskegee Syphilis Study to document the already known course of syphilis, which led to the men suffering sores, fever, hair loss, weight loss,
headaches, paralysis, blindness, dementia, and death. 3 In exchange for
free meals, medical exams, and burial insurance, the researchers promised the men that they would provide treatment for their “bad blood,”
which could include “anemic blood to muscle aches, general malaise,
disorders such as parasitic infections, gonorrhea, syphilis, and other venereal diseases.” 4 Not only did the researchers lie about the purpose of
the study, but also they intentionally deprived these men of “demonstrably effective treatment in order not to interrupt the project, long
1.

Throughout the Article, I use economically disadvantaged to discuss children
who lack access to essential goods such as food, housing, and health care.
Although the term can be over inclusive, for clarity, I have used the word
accepted in the medical research community. For more discussion, see Carol
Levine, Changing Views of Justice after Belmont: AIDS and the Inclusion
of “Vulnerable” Subjects, in The Ethics of Research Involving Human
Subjects: Facing the 21st Century 105, 110 (Harold Y. Vanderpool ed.,
1996) (“Underlying the protectionist view of the selection of subjects is the
assumption that research is risky . . . . If this is true, then subjects should be
selected in a way that protects those whose social, demographic, or economic
characteristics make them particularly vulnerable to coercion and exploitation.”).

2.

Harriet A. Washington, Medical Apartheid: The Dark History of
Medical Experimentation on Black Americans from Colonial
Times to the Present 159–66 (2006) [hereinafter Washington]. See also
Deleso Alford Washington, Examining the “Stick” of Accreditation for Medical
Schools Through Reproductive Justice Lens: A Transformative Remedy for
Teaching the Tuskegee Syphilis Study, 26 St. John’s J. C.R. & Econ. Dev.
153, 158 (2011) [hereinafter Alford Washington] (noting that an earlier study
had confirmed the existence of mass treatment options for syphilis); James
H. Jones, Bad Blood: The Tuskegee Syphilis Experiment 2–4, 206–
08 (rev. ed., 1993) (describing the symptoms of syphilis and discussing the
decision to withhold treatment from participants in the Tuskegee Syphilis
Experiment).

3.

Jones, supra note 2, at 4.

4.

Washington, supra note 2, at 162.
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after such treatment became generally available,” causing the unnecessary disability and death of the men, their wives, and their children. 5
The study was not a therapeutic study because it was not testing a
possible treatment of syphilis and blocked any access to treatment. 6
Additionally, the study was not a non-therapeutic study to attain generalizable knowledge because the medical community had already documented the disease process of syphilis. 7 Thus, there was nothing gained
from the study other than exploiting economically disadvantaged minorities. 8
The egregiousness of this study led to the creation and recognition
of three Bioethical Principles: Respect for Persons (informed consent); 9
5.

Belmont Report: Ethical Principles and Guidelines for the Protection of
Human Subjects of Research, Report of the National Commission for the
Protection of Human Subjects of Biomedical and Behavioral Research, 44
Fed. Reg. 23,192, 23,194 (Apr. 18, 1979) [hereinafter Belmont Report];
Washington, supra note 2, at 159–60, 163. See also Alford Washington,
supra note 2, at 177 (“By applying a reproductive justice lens to a reexamination of the Tuskegee Syphilis Study, one ascertains that the government
denied the women directly impacted by the study the right to not bear a
child with congenital syphilis, because of the government doctors’ intention
to study the effect of untreated syphilis on men (the husbands and intimate
partners of the women who contracted syphilis) and, unbeknownst to them,
passed the disease on to their unborn children.”).

6.

See infra note 19 (distinguishing therapeutic from non-therapeutic research
studies).

7.

See supra note 2.

8.

Fred Gray, whose life and work we celebrate with this symposium, filed a
lawsuit on behalf of the men who participated in the Study. Fred D. Gray,
The Tuskegee Syphilis Study: The Real Story and Beyond 84
(1998). After the lawsuit was filed on July 24, 1973, the government settled
the case for approximately ten million dollars ($37,500 to research participants
with syphilis who were alive as of July 23, 1973, $15,000 to the heirs of
research participants with syphilis, $16,000 to research participants without
syphilis who were alive as of July 24, 1973; and $5,000 to the heirs of research
participants without syphilis). Id. at 98; Jones, supra note 2, at 216–17.
Researchers directly involved in the study never apologized. Id. at 219.

9.

See 45 C.F.R. § 46.408 (2015) (providing “[r]equirements for permission by
parents or guardians and for assent by children”). For a detailed discussion
regarding the balance between the need for medical research studies in children
and the need for informed consent, see Additional Protections for Children
Involved as Subjects in Research, 48 Fed. Reg. 9814 (Mar. 8, 1983) (“[HHS]
is prescribing additional requirements for protection of children involved as
subjects in research”); Protection of Human Subjects, 43 Fed. Reg. 31,786
(July 21, 1978) (“Adequate provisions must be made to obtain the assent of
the child and the consent or permission of the parents or guardians whenever
these are necessary.”); Nat’l Insts. of Health, U.S Dep’t of Health &
Human Servs., NIH Policy and Guidelines on the Inclusion of
Children as Participants in Research Involving Human Subjects
(Mar. 6, 1998), http://grants.nih.gov/grants/guide/notice-files/not98-024.
html [https://perma.cc/F993-Z6AS] [hereinafter NIH Guide] (setting forth
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Beneficence (the best interest of the individual participating in the research based on a benefit-risk analysis); 10 and Justice (who participates
in medical research and what benefit has to be given to groups who
participate in medical research), 11 which govern all medical research
studies conducted by or funded by the federal government, except for
specified circumstances, like emergency settings. 12 Although these
Bioethical Principles have the force of law, 13 medical research studies
conducted by or funded by the federal government continue to exploit
“the policy and guidelines on the inclusion of children in research involving human
subjects that is supported or conducted by the National Institutes of Health
(NIH)”); Nat’l Comm’n for the Prot. of Human Subjects of Biomedical & Behavioral Research, U.S. Dep’t of Health, Educ. &
Welfare, Publ’n No. (OS) 77-0004, Report and Recommendations:
Research Involving Children 43–47 (1977) [hereinafter Commission
Report] (discussing informed consent in the context of “research involving
children”). Paul Ramsey and Richard McCormick provided the most influential discussion regarding autonomy and the use of children in medical research studies. Paul Ramsey argued that there was a need for assent from
children participating in medical research studies, and that “no parent is
morally competent to consent that his child shall be submitted to hazardous
or other experiments having no diagnostic or therapeutic significance for the
child himself.” Paul Ramsey, The Patient as Person: Explorations
in Medical Ethics 13 (1970). Conversely, Richard McCormick argued that
children should participate in medical research studies with parental consent
if it would benefit the child, even if only morally, and is a reasonable presumption of the child’s wishes. Richard A. McCormick, Experimentation in
Children: Sharing in Sociality, 6 Hastings Ctr. Rep. 41, 41–42, 44 (1976).
10.

See 45 C.F.R. §§ 46.404–.407 (2016) (requiring an analysis of the risks and
benefits to children as research subjects as a condition to receiving HHS funding or participation); NIH Guide, supra note 9 (summarizing “additional
requirements under the HHS Regulations 45 CFR 46, Subpart D”); Commission Report, supra note 9, at 42–43 (assessing the “[r]isks and benefits
of research involving children”). See also Loretta M. Kopelman, Children as
Research Subjects: Moral Disputes, Regulatory Guidance, and Recent Court
Decisions, 73 Mount Sinai J. Med. 596, 597 (2006) (arguing that as the
courts have “reinforced the fact that the ‘best interest’ standard must be
used for incompetent persons . . . . the failure to clarify the meaning of the
pediatric regulations has sometimes misled generally risk-adverse institutions
and dedicated investigators about what is permissible”); Michelle Oberman
& Joel Frader, Dying Children and Medical Research: Access to Clinical
Trials as Benefit and Burden, 29 Am. J.L. & Med. 301 (2003) (analyzing
the intricacies of determining the “best interests” of the child in medical
research).

11.

See 45 C.F.R. § 46.111(a)(3) (2015) (stating that the “IRB should take into
account the purposes of the research and the setting in which the research
will be conducted”). This section also prohibits the targeting of children for
use in medical research studies. Id. § 46.111(b).

12.

21 C.F.R. §§ 50.23–.24 (2012).

13.

45 C.F.R. § 46.101 (2015).
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economically disadvantaged minorities by using them for participation
in medical research studies for which there is no benefit.
Much of the work discussing the history and legacy of the Tuskegee
Syphilis Study has focused on the violations of the Respect for Persons
and Beneficence Principles. 14 The discussion has rarely focused on the
Justice Principle that prohibits exploitation. 15 Exploitation is defined
as the use of populations for research from which they will not benefit.16
My Article begins to fill this void by critically analyzing the current
limitations of the Justice Principle to address structural and institutional racial biases in health care, which allow economically disadvantaged minorities to be exploited in medical research studies as they were
in the Tuskegee Syphilis Study. Using research conducted on economically disadvantaged minority children as an example, my Article shows
how even after the creation of the Justice Principle and the passage of
the civil rights laws, structural and institutional racial biases remain
and have led to the continued exploitation of economically disadvantaged minorities in medical research studies.
Part I of the Article provides a descriptive overview of the purpose
and structure of medical research studies and examines the parameters

14.

See Jones, supra note 2, at 216–17 (discussing harm endured by participants
in the Tuskegee Syphilis Study who participated without informed consent).
See generally Alford Washington, supra note 2 (addressing a “traditionally
overlooked, historically marginalized and devalued aspect of our society:
women in general and in particular, Black women, specifically in relation to
healthcare, research and medical education”); Tuskegee’s Truths: Rethinking the Tuskegee Syphilis Study (Susan M. Reverby, ed., Univ.
of N.C. Press, 2000) [hereinafter Tuskegee’s Truths] (discussing how men
participated in the Tuskegee Syphilis Study “under the guise of treatment”);
Susan M. Reverby, Examining Tuskegee: The Infamous Syphilis
Study and Its Legacy (2009).

15.

Belmont Report, supra note 5, at 23,194. The Justice Principle also prohibits
targeting. Targeting is the systematic selection of research subjects who are
from vulnerable populations, such as racial minorities, children, and the economically disadvantaged, “because of their easy availability, their compromised position, or their manipulability, rather than for reasons directly related
to the problem being studied.” Id. For a more detailed discussion concerning
targeting, see Ruqaiijah Yearby, Missing the “Target”: Preventing the Unjust
Inclusion of Vulnerable Children for Medical Research Studies, 42 Am. J.L.
& Med. (forthcoming 2017) (discussing continued targeting in medical
research involving children and proposing recommendations to prevent further
targeting).

16.

See Belmont Report, supra note 5, at 23,194 (“[T]he selection of research
subjects needs to be scrutinized in order to determine whether some classes
(e.g., welfare patients, particular racial and ethnic minorities, or persons
confined to institutions) are being systematically selected simply because of
their easy availability, their compromised position, or their manipulability,
rather than for reasons directly related to the problem being studied.”).
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of the Justice Principle. Part II discusses the structural and institutional biases that prevent economically disadvantaged minority children from accessing health care and how this leads to their exploitation
in medical research studies. Structural racial bias measures how nonrace based factors, such as the delivery of health care based on ability
to pay, indirectly affects economically disadvantaged minority children’s access to health care, whereas institutional racial bias focuses on
the direct effects of institutional actions on economically disadvantaged
minority children’s access to health care. In Part III, I propose several
ways to put an end to exploitation, a violation of the Justice Principle
in medical research studies.
Specifically, I suggest that the Justice Principle be redefined to
include the Human Development Approach that requires researchers to
provide a benefit to the population from which the research subjects
originated that alleviates some of the populations’ underlying problems,
such as lack of access to health care. This type of benefit is required
because oftentimes either the researcher’s institution or the researcher’s
actions have caused some of the underlying problems, such as lack of
access to health care. 17 To measure whether the research fulfills the
Human Development Approach and provides a benefit that alleviates
some of the underlying problems, researchers should be required to use
the Vulnerability and Equity Impact Assessment (VEIA) tool, which I
have created based on the Health Equity Impact Assessment tool.18
Using the VEIA, a newly created Board of Children would be
responsible for approving all medical research studies seeking U.S.
government funding that plan to use children. The Board would use
the VEIA to determine if the research would exploit economically
disadvantaged minority children in violation of the redefined Justice
Principle.
Redefining the Justice Principle to include the Human Development
Approach, implementing the VEIA, and creating a Board to review all
17.

See Alex John London, Justice and the Human Development Approach to
International Research, Hastings Ctr. Rep. 24, 32 (2005) (“[T]he minimalist
approach does little to bring attention to the root causes of the developing
world populations’ most pressing health needs. As a result, it perpetuates an
ad hoc and piecemeal approach to the health needs of populations that already
bear the greatest burden of disease and deprivation.”).

18.

See Rebecca Haber, Wellesley Inst., Health Equity Impact Assessment: A Primer (2010), http://www.wellesleyinstitute.com/wp-content/
uploads/2011/02/Health_Equity_Impact_Assessment_Haber.pdf [https://
perma.cc/Z3YT-HLL9] (“HEIA is a tool used to analyze a new program or
policy's potential impact on health disparities and/or on health disadvantaged
populations. It is an adaptation of health impact assessment (HIA) with an
explicit focus on equity.”). See also Rainer Fehr, Environmental Health
Impact Assessment., Evaluation of a Ten-Step Model, 10 Epidemiology Res.
Inc. 618, 618 (1999) (identifying “key elements of an integrated environmental
health impact assessment model”).
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medical research studies using children will prevent economically disadvantaged minority children from being exploited in medical research
studies for the benefit of an unworthy society.

I. Medical Research Studies Involving Children:
The Structure and History
There are two types of medical research studies involving human
subjects: non-therapeutic and therapeutic. 19 Regardless of the type of
medical research study, all studies using children entail risk of psychological and physical harm, as well as the possibility of stigma. In
fact, countless children have suffered harm as a result of participating
in medical research studies, often without any benefit to children. 20
However, economically disadvantaged minority children have been and
continue to be overrepresented in medical research studies that do not
provide a benefit to economically disadvantaged minority children.21
This violates the Justice Principle.
The Justice Principle was created by incorporating social justice
into scientific endeavors to protect populations from being exploited. In
19.

Therapeutic or beneficial research “means that if the hypothesis of the research
is correct, the subjects who participate should receive direct benefit from
their participation.” Leonard H. Glantz, Research with Children, 24 Am.
J.L. & Med. 213, 231 (1998). Non-therapeutic research, on the other hand,
involves “no prospect of direct benefit to individual subjects, but [is] likely
to yield generalizable knowledge about the subject's disorder or condition.” Id.

20.

Id. at 215–17 (discussing various historical experiments subjecting children
to risk and harm); see also Susan Lederer & Michael Grodin, Historical
Overview: Pediatric Experimentation, in Children as Research Subjects:
Science, Ethics, and Law 3–20 (1994) (surveying the history of the use
of children as medical research subjects). Children have been exploited in
medical research studies for conditions that were not limited to children. Id.
Moreover, many medical research studies conducted on children have no
scientific value and are stigmatizing. See Solomon R. Benatar, Global Health
and Justice: Re-Examining Our Values, 27 Bioethics 297, 301–02 (2013)
(discussing how grant money could be distributed more effectively to reduce
child mortality); Iain Chalmers & Paul Glasziu, Avoidable Waste in the Production and Reporting of Research Evidence, 374 Lancet 86, 86–89 (2009)
(discussing wasteful and unnecessary research practices of the modern
research landscape); Washington, supra note 2, at 271–96 (discussing scientific research that has targeted and stigmatized Black children); Lainie
Friedman Ross, Children in Medical Research: Access Versus
Protection 48, 50 (2006) (discussing the overrepresentation of Black children in various categories of research, including potentially stigmatizing research).

21.

Washington, supra note 2, at 271–96; Ross, supra note 20, at 48, 50;
Vernellia R. Randall, Slavery, Segregation and Racism: Trusting the Health
Care System Ain’t Always Easy! An African American Perspective on Bioethics, 15 St. Louis U. Pub. L. Rev. 191, 199 (1996).

1177

Case Western Reserve Law Review·Volume 67·Issue 4·2017
Exploitation in Medial Research

1979, the first discussion of the Justice Principle in medical research
studies appeared in the United States Belmont Report. 22 This report—
mandated by the United States Congress—not only defined the Justice
Principle, but also provided the framework for which to apply the principle to medical research studies. 23 Since the codification of the Belmont
Report in 1986, 24 the Justice Principle has been applied to all medical
research studies conducted by or funded by the federal government,
except in emergency settings, as a means to protect vulnerable populations, such as economically disadvantaged minority children from being exploited. 25
A. Structure of Medical Research Studies Involving Human Subjects

A non-therapeutic medical research study is conducted to obtain
generalizable scientific knowledge. 26 This research is done to learn more
“about the subjects’ disorder or condition, which is of vital importance
for the understanding or amelioration of the subjects’ disorder or condition.” 27 An example of non-therapeutic research is the Kennedy Krieger
lead study. 28
In the 1990s, Kennedy Krieger Institute researchers investigating
cheap lead abatement techniques partnered with landlords to partially
abate lead tainted housing in Baltimore, Maryland. 29 In order to test
the efficacy of the abatement procedures, the researchers—in collaboration with the landlords—ensured that only families with healthy children lived in the lead tainted housing by agreeing to pay for lead abate-

22.

Belmont Report, supra note 5, at 23,194. In fact, the Justice Principle was
found only in the Belmont Report until 2000, when the World Medical Association added the principle to the Declaration of Helsinki, a renowned document of bioethics for medical research. World Med. Ass’n, Declaration
of Helsinki—Ethical Principles for Medical Research Involving
Human Subjects (amended 2013), http://www.wma.net/en/30publications
/10policies/b3/ [https://perma.cc/K73Y-9KTF]. For a discussion regarding
the ethical documents that discuss the use of children in research trials, see
Duane Alexander, Regulation of Research with Children: The Evolution from
Exclusion to Inclusion, 6 J. Health Care L. & Pol’y 1 (2002).

23.

Belmont Report, supra note 5, at 23,192.

24.

See Ross, supra note 20, at 23 n.101.

25.

45 C.F.R. § 46.101, 46.111 (2015) (identifying the scope of the policy’s
application and summarizing criteria for compliance).

26.

Id. § 46.406(c).

27.

Id.

28.

See Grimes v. Kennedy Krieger Inst., Inc., 782 A.2d 807, 811–17 (Md. 2001)
(describing the Kennedy Krieger study in detail).

29.

Id. at 811–12.
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ment procedures if the landlords rented to families with young children. 30 Although the information given to parents “implied that the
study was protecting their children from lead damage and promised to
inform parents of any hazards,” 31 the study was non-therapeutic32
because it was conducted to find out more “about the subjects’ disorder
or condition which is of vital importance for the understanding or amelioration of the subjects’ disorder or condition . . . .” 33
A therapeutic medical research study tests a vaccine, drug, or
medical device for the treatment of a disease. 34 An example of a therapeutic medical research study is the testing of HIV/AIDS drugs. There
are five phases of therapeutic medical research studies: Phase 0, I, II,
III, and IV. 35 Using drug medical research studies as an example, each
phase is discussed below.
In a Phase 0 drug study, research is conducted using at most ten
people and involves the administration of small doses of an experimental drug over a short period of time to determine if there is any
pharmacological effect. 36 The purpose of the study is to evaluate whether there is any effect in humans before undertaking Phase I and II
drug studies. 37 Unlike Phase I drug studies, there is no therapeutic
30.

Id. at 812.

31.

Washington, supra note 2, at 292.

32.

Grimes, 782 A.2d at 811–12. There were many problems with the study. In
fact, the researchers did not notify the parents of their children’s elevated
lead levels or lead hot spots in the house. Id. at 825–31. As a result, many of
the healthy children suffered exposure to lead. Id. Exposure to lead can cause
inattention, irritability, hyperactivity, learning and reading delays, delayed
growth and hearing loss, permanent brain damage, and even death. Lead
Exposure in Children Affects Brain and Behavior, Am. Acad. of Child &
Adolescent Psychiatry (Nov. 2012), http://www.aacap.org/aacap/
fffprint/article_print.aspx?dn=Lead-Exposure-In-Children-Affects-BrainAnd-Behavior-045 [https://perma.cc/L4AP-YNTN?type=image] [hereinafter
Lead Exposure in Children].

33.

45 C.F.R. § 46.406(c) (2015).

34.

See, e.g., id. § 46.405 (“HHS will conduct or fund research in which the IRB
finds that more than minimal risk to children is presented by an intervention
or procedure that holds out the prospect of direct benefit for the individual
subject, or by a monitoring procedure that is likely to contribute to the subject’s well-being . . . .”).

35.

U.S. Nat’l Insts. of Health, Glossary of Common Site Terms, Clinical
Trials.gov, http://clinicaltrials.gov/ct2/info/glossary#Phasel [https://
perma.cc/T2FJ-JAF3] (last visited Feb. 20, 2017) [hereinafter Clinical Trial
Glossary].

36.

See id. (explaining that Phase 0 “involv[es] very limited human exposure to
the drug, with no therapeutic or diagnostic goals”).

37.

What are the Phases of Clinical Trials?, Am. Cancer Soc’y, https://
www.cancer.org/treatment/treatments-and-side-effects/clinical-trials/what-
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intent and little to no toxic effect in a Phase 0 drug study, which is
primarily done for cancer drugs and therapies. 38
In a Phase I drug study, research is conducted using a small number
of subjects, less than 100 people, to obtain information regarding the
safety and efficacy of the candidate drug on human subjects. 39 Research
that obtains information from several hundred subjects regarding the
subjects’ immune system’s response, the efficacy of the drug on different
populations, and the effect of different doses on the population is conducted in a Phase II drug study. 40
After preliminary evidence has been obtained suggesting the effectiveness of a drug, a Phase III drug study is conducted “to gather additional information to evaluate the overall benefit-risk relationship of the
drug and provide an adequate basis for physician labeling.” 41 Researchers determine the efficacy of the drug for treating the disease by following anywhere from 300 to 3,000 subjects. 42 This is the last Phase before
the drug is marketed and distributed. Phase IV is the final step in drug
studies. It includes “postmarket requirement and commitment studies
. . . . [to] gather additional information about a drug’s safety, efficacy,
or optimal use.” 43 The main difference between each phase is the
purpose of the study and the benefit. In Phase 0, I, and II studies, the

you-need-to-know/phases-of-clinical-trials.html [https://perma.cc/BN2GRJ3L] (last updated Feb. 7, 2017).
38.

Id.; Clinical Trial Glossary, supra note 35.

39.

Step 3: Clinical Research, U.S. Food & Drug Admin., https://www
.fda.gov/ForPatients/Approvals/Drugs/ucm405622.htm#Clinical_Research
_Phase_Studies [https://perma.cc/EW79-X2AP] (last updated Oct. 14,
2016) [hereinafter FDA Clinical Research]; Clinical Trial Glossary, supra
note 35.

40.

FDA Clinical Research, supra note 39.

41.

Ruth Frost, Trial Phase Values—Include v4.4, Nat’l Cancer Inst.,
https://wiki.nci.nih.gov/display/CTRPdoc/Trial+Phase+Values+-+Include
+v4.4 [https://perma.cc/S8Y4-QGX9] (last updated Dec. 07, 2016).

42.

FDA Clinical Research, supra note 39.

43.

Clinical Trial Glossary, supra note 35. See also Leslie Pickering Francis,
Legitimate Expectations, Unreasonable Beliefs, and Legally Mandated Coverage of Experimental Therapy, 1 Ind. Health L. Rev. 213, 228 (2004)
(“Phase IV trials undertake continued collection of data after a new drug is
given marketing approval based on data from earlier trials. The goal of Phase
IV is to collect data on an ongoing basis as an approved therapy becomes
employed in the general population of patients in need of treatment. Distribution of a therapy into the general population of patients, outside the research
context, may reveal quite different aspects of the therapy’s risks and benefits.”).
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goal is primarily the attainment of scientific knowledge, whereas in
Phase III and IV studies, the goal is treatment. 44
Overall, regardless of the type of research being conducted, therapeutic or non-therapeutic, medical research studies offer the prospect
of benefit to society. However, the Justice Principle requires that the
population from which those serving as research subjects originate receive a benefit. Thus, if economically disadvantaged minority children
serve as research subjects for medical research studies, whether therapeutic or non-therapeutic, all economically disadvantaged minority
children should benefit from the studies either by receiving access to
the drug or having the knowledge ascertained from the research used
to assist them.
B. The Belmont Report

In the early 1970s, the U.S. Senate Committee on Labor and Human Resources held hearings on some of America’s most egregious
medical research studies, such as the Willowbrook study45 and the
44.

See Francis, supra note 43, at 227–28 (describing the purpose and scientific
value underlying each phase).

45.

For fifteen years (1956–1971) researchers conducted non-therapeutic medical
research studies on children at the Willowbrook State School—an institutional
facility for “mentally defective persons” on Staten Island, New York—to
obtain scientific knowledge of “the natural history of hepatitis and the effects
of gamma globulin in preventing or moderating its effects.” Carl H. Coleman et al., The Ethics and Regulation of Research with Human
Subjects 39 (2005). Researchers infected healthy children—thus, the study
was not to treat a disease from which the children suffered. Early in the
study, the children were fed “extracts of stools from infected children, while
later subjects received injections of more purified virus preparations.” Id.
The children were then gauged to determine the effects of gamma globulin
in combating it. A hepatitis vaccine was developed due to this study. Id. As
a result of the study, healthy children were infected with a life-long debilitating disease so that researchers could develop a vaccine, which the infected
children could never use, and as a result of the studies, the children were
subjected to costly treatment for the rest of their lives. The researchers defended their research because there were outbreaks of hepatitis at the school,
so they assumed that the children would eventually acquire the disease. Id.
At the time of the study, several major medical journals (the Journal of the
American Medical Association and the New England Journal of Medicine)
published the results of the study, commending the researchers for their use
of vulnerable children and asserting that the children actually benefited “from
being infected under carefully controlled research conditions and receiving expert attention.” Id. However, some researchers and scholars disagreed, alluding to the fact that healthy children were fed stool extracts and received no
benefit from the study because there is no cure for hepatitis. Furthermore,
many argued that the choice to use that population seems to have been driven
by the convenience of the children, not any lofting moral intentions. See id. at
40 (describing coercive tactics used by institutional directors to secure the
consent by parents for their childrens’ participation in the study).
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Tuskegee Syphilis study. 46 As a result of the hearings, Congress created
the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (Commission) 47 and imposed a moratorium on research conducted or supported by the U.S. Department of
Health and Human Services (HHS) 48 until adequate protections for
research subjects were developed. 49
The Belmont Report was an outgrowth of the Commission’s deliberations regarding ethical protections and a 1976 conference at the
Smithsonian Institution’s Belmont Conference Center. 50 In the Belmont
Report, the Commission selected Justice as one of the three fundamental ethical principles to address the exploitation of vulnerable groups
for medical research studies. 51 The Commission noted that in the United
States the burden of participating in medical research studies was borne
principally by the economically disadvantaged while the rich enjoyed

46.

The Tuskegee Syphilis Study, conducted from 1932 through 1972, denied
standard access to treatment to economically disadvantaged African-American
men. See Belmont Report, supra note 5, at 23,194 (describing the recruitment
of “disadvantaged, rural black men” to the Tuskegee study); Jones, supra
note 2, at 206–19 (discussing the evolution of the Tuskegee Study).

47.

The Commission was composed of eleven members appointed by the Secretary
of HHS. National Research Act of 1974, Pub. L. No. 93-348, § 201(a), 88
Stat. 342, 348 (codified as amended in scattered sections of 42 U.S.C). The
National Research Act advised the Secretary of HHS to choose the members
of the Commission from “individuals distinguished in the fields of medicine,
law, ethics, theology, philosophy, humanities, the biological, physical, behavioral, and social sciences, health administration, government, and public
affairs.” Id. § 201(b)(1). Five of the members of the Commission had to be
individuals “engaged in biomedical or behavioral research involving human
subjects.” Id. Members of the Commission included: Dorothy I. Height, President, National Council of Negro Women, Inc., Albert R. Jonsen, Ph.D., Associate Professor of Bioethics, University of California at San Francisco, and
Patricia King, J.D., Associate Professor of Law, Georgetown University Law
Center, and others. Belmont Report, supra note 5, at 23,192.

48.

Prior to 1980, the U.S. Department of Health and Human Services (HHS)
was called the U.S. Department of Health, Education, and Welfare. Department of Education Organization Act, Pub. L. No. 96-88 § 509(a), 93 Stat.
668, 695 (1979) (codified at 20 U.S.C. § 3508 (2006)). However, to avoid
confusion when discussing events before and after the name change, I refer
to the agency only as HHS.

49.

National Research Act § 472(b)(1), 88 Stat. at 343 (codified as amended at
42 U.S.C. § 289l-1). The National Research Act of 1974 also required HHS
to develop and publish policies for the protection of human subjects in the
Code of Federal Regulations. Id. § 205, 88 Stat. at 351.

50.

Belmont Report, supra note 5, at 23,192.

51.

Id. at 23,194. The two other principles were Respect for Persons and Beneficence. Id.
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the benefits, as evidenced by the Tuskegee Syphilis Study. 52 To address
this inequitable burdening of the poor and minorities, the Report included the Justice Principle based on John’s Rawls Egalitarian theory
as refined by Tom Beauchamp and James Childress.
According to John Rawls, the Justice Principle encompasses fairness and equity, which “are not subject to political bargaining or to the
calculus of social interests.” 53 Unlike Utilitarianism that allows for harm
for the benefit of the greater good, Rawls’ notes that “justice denies
that the loss of freedom for some is made right by a greater good shared
by others. It does not allow that the sacrifices imposed on a few are
outweighed by the larger sum of advantages enjoyed by many.” 54 Adding to John Rawls’ theory, Tom Beauchamp and James Childress submit that Egalitarianism imposes a “positive societal obligation to reduce
or eliminate barriers that prevent fair equality of opportunity, an obligation that extends to programs to correct or compensate for various
disadvantages.” 55 Based on this refined Egalitarian theory of Justice,
the Commission used the Justice Principle to answer the questions:
“Who ought to receive the benefits of research and bear its burdens?”56
Specifically, the Commission defined what is just and unjust in the use
of research subjects.
In selecting research subjects, the Justice Principle requires that
researchers ensure that disadvantaged groups such as minorities, women, children, the institutionalized mentally infirm, prisoners, and the
economically disadvantaged 57 are not “being systematically selected
simply because of their easy availability, their compromised position,
or their manipulability, rather than for reasons directly related to the
problem being studied.” 58 The Commission reasoned that:
[W]henever research supported by public funds leads to the development of therapeutic devices and procedures, justice demands
both that these not provide advantages only to those who can
afford them and that such research should not unduly involve
52.

Id.

53.

John Rawls, A Theory of Justice 3–4 (Harvard Univ. Press rev. ed.,
1999). Widely considered as the most significant contribution to law and
philosophy, John Rawls created Egalitarianism as an alternative concept to
the Utilitarian theory of justice. See id. at xvii–xviii (presenting an “alternative
systematic account of justice”).

54.

Id. at 3.

55.

Tom Beauchamp & James Childress, Principles of Biomedical
Ethics 248 (6th ed. 2009).

56.

Belmont Report, supra note 5, at 23,194.

57.

Id. at 23,194, 23,196–97.

58.

Id. at 23,194.
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persons from groups unlikely to be among the beneficiaries of subsequent applications of the research. 59

According to the Commission, an injustice occurs during medical
research when a benefit is denied to a person without good reason or a
burden is unduly imposed on a person, whereas Justice requires “that
equals ought to be treated equally.” 60 As applied to medical research,
“the principle of justice gives rise to moral requirements that there be
fair procedures and outcomes in the selection of research subjects” on
two levels: individual and social. 61 On the individual level, researchers
should include the disadvantaged in potentially beneficial research that
is usually reserved for the rich, 62 instead of using them for non-therapeutic and dangerous medical research studies. On the social level, researchers must draw a distinction “between classes of subjects that
ought, and ought not, to participate in any particular kind of research,
based on the ability of members of that class to bear burdens and on
the appropriateness of placing further burdens on already burdened persons.” 63 The Belmont Report noted that it was not fair for the economically disadvantaged, who rely on public funds for health care, to
be considered as preferred research subjects for publicly funded research
because of their need to access health care. 64 Thus, there is an order of
preference in the selection of research subjects, such that researchers
should use the rich before the economically disadvantaged, the majority
before minorities, and adults before children. Moreover, there is a requirement that if a population serves as research subjects for the studies, that population should receive a benefit from the research. 65
On an individual level, the Justice Principle requires inclusion of
vulnerable groups for potentially beneficial research, 66 while on a social
59.

Id. (emphasis added).

60.

Id.

61.

Id. at 23,196.

62.

Id.

63.

Id.

64.

Id. at 23,197.

65.

The requirement of a benefit to the individuals who serve as research subjects
is addressed by the Beneficence Principle. 45 C.F.R. §§46.404–.407 (2010);
NIH Guide, supra note 9; Commission Report, supra note 9, at 5–10; see
also Kopelman, supra note 10, at 597 (discussing how the United States
balances potential harms and benefits in approving studies); Oberman &
Frader, supra note 10, at 301 (discussing how the perceived vulnerability of
children to medical experimentation led to federal regulation). It is also
discussed in the prohibition against targeting under the Justice Principle.
See Yearby, supra note 15 (discussing how the Justice Principle prohibits
targeting subjects from vulnerable populations).

66.

Belmont Report, supra note 5, at 23,196.
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level this inclusion must be balanced to protect vulnerable groups from
being overburdened. 67 Nevertheless, even after researchers balance the
individual and social level requirements of the Justice Principle, the use
of certain classes of people for research may be unjust because of “social,
racial, sexual and cultural biases institutionalized in society” that place
a class of people in a vulnerable and compromised position, easily manipulated into participation in medical research studies, without any benefit to the population from which the subject originated. 68
For example, over three decades of empirical research studies show
that racial bias institutionalized in society prevents many African Americans from receiving a quality education, obtaining jobs, and accessing
housing in safe, diverse, and environmentally-friendly neighborhoods. 69
67.

Id.

68.

Id.

69.

See, e.g., Martha E. Lang & Chloe E. Bird, Understanding and Addressing
the Common Roots of Racial Health Disparities: The Case of Cardiovascular
Disease & HIV/AIDS in African Americans, 25 Health Matrix 109, 121–
24 (2015) (discussing how negative health results from the somatic effects of
racism and an allostatic load, how CVD rates have declined slower in African
American populations than white populations, and how the mortality rate
for African Americans from CVD is greater than in white populations);
Ruqaiijah Yearby, Sick and Tired of Being Sick and Tired: Putting an End
to Separate and Unequal Health Care in the United States 50 Years After
the Civil Rights Act of 1964, 25 Health Matrix 1 (2015) (discussing racially
separate and unequal health care in the United States); Richard Delgado,
Two Ways to Think About Race: Reflections on the Id, the Ego, And Other
Reformist Theories of Equal Protection, 89 Geo. L.J. 2279 (2001)
(discussing the application of Critical Race Theory to economic issues);
Andrew Grant-Thomas & John A. Powell, Toward a Structural Racism
Framework, Poverty & Race, Nov.–Dec. 2006, at 3 (arguing for a
structural racism framework as an approach to remedying inequality); Ian F.
Haney López, The Social Construction of Race: Some Observations on
Illusion, Fabrication, and Choice, 29 Harv. C.R.-C.L. L. Rev. 1, 6–7, 10–
17 (1994) (rejecting the idea of biological race and criticizing the continued
reliance of conceptions of biological race in the law); Charles R. Lawrence
III, The Id, the Ego, and Equal Protection: Reckoning with Unconscious
Racism, 39 Stan. L. Rev. 317 (1987) (critiquing the doctrine of discriminatory purpose and discussing unconscious racism); Kimberle Crenshaw,
Demarginalizing the Intersection of Race and Sex: A Black Feminist Critique
of Antidiscrimination Doctrine, Feminist Theory and Antiracist Policies, U.
Chi. Legal F. 139, 139–40 (1989) (stating how Black women are marginalized in conversations about racism and sexism). These disadvantages affect
the health of those that are disadvantaged. See Paula Braveman et al.,
Socioeconomic Disparities in Health in the United States: What the Patterns
Tell Us, 100 Am. J. Pub. Health S186, S189 (Supp. 1 2010) (discussing the
results of a study which found that relative advantage in society, rather than
merely whether one is above or below a certain income level, is an indicator
of health); Leith Mullings & Amy J. Schulz, Intersectionality and Health: An
Introduction, in Gender, Race, Class and Health: Intersectional
Approaches 3, 12 (Leith Mullings & Amy J. Schulz eds. 2006) (discussing
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Studies show that African Americans seeking employment have a harder time obtaining employment because non-African American managers
tend to hire more Caucasians. 70 Also, African Americans with non-Caucasian names receive fifty percent less callbacks than African Americans
with Caucasian sounding names. 71 As a result, many African Americans
are more likely to be unemployed or employed with no health insurance.
Lacking health insurance or money to pay for health care, African
Americans are left in a compromised position and easily manipulated
into participating in medical research studies to obtain access to health
care. Consequently, even if researchers fairly select African Americans
as research subjects, these institutional racial biases that prevent them
from accessing health care make their use as research subjects a violation of the Justice Principle because they will not receive a benefit
even if the research leads to a treatment, since they do not have access
to health care. 72
Beginning in the 1980s, the Belmont Report in its entirety, was
adopted by sixteen federal agencies and departments, including HHS,
and codified in 45 C.F.R. Part 46 (the Common Rule). 73 In fact, not
only did the Common Rule make the Justice Principle law, but it also
explicitly defined the groups protected by the Justice Principle as

how different forms of racism affect health, such as structural racism, institutional racism, and interpersonal racism); Pamela Braboy Jackson & David
R. Williams, The Intersection of Race, Gender, and SES: Health Paradoxes,
in Gender, Race, Class and Health: Intersectional Approaches
131 (Leith Mullings & Amy J. Schulz eds. 2006) (examining how race,
gender, and socioeconomic status interact to impact health); Ruth E. Zambrana & Bonnie Thornton Dill, Disparities in Latina Health: An Intersectional
Analysis, in Gender, Race, Class and Health: Intersectional
Approaches 192 (Leith Mullings & Amy J. Schulz eds. 2006) (examining the
effects of various factors on health disparities); Peter Franks et al., The Burden
of Disease Associated with Being African-American in the United States and
the Contribution of Socio-Economic Status, 62 Soc. Sci. & Med. 2469 (2006)
(finding that socio-economic status differences in African-Americans, compared to that of whites, contribute to a disparity in health-related quality of
life).
70.

Michael Luo, In Job Hunt, College Degree Can’t Close Racial Gap, N.Y.
Times (Nov. 30, 2009), http://www.nytimes.com/2009/12/01/us/01race
.html?_r=0 [https://perma.cc/8P78-WZZ3].

71.

Marianne Bertrand & Sendhil Mullainathan, Are Emily and Greg More
Employable Than Lakisha and Jamal? A Field Experiment on Labor Market
Discrimination (Nat’l Bureau of Econ. Research, Working Paper No. 9873,
2003).

72.

See Belmont Report, supra note 5, at 23,196.

73.

See Ross, supra note 20, at 23 n.101 (listing agencies).
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vulnerable populations that shall not be exploited. 74 Vulnerable populations include minorities, children, prisoners, pregnant women, mentally disabled persons, and economically or educationally disadvantaged
persons. 75 The Common Rule generally governs all research studies
conducted by or funded by the federal government. 76
C. The Common Rule

Institutions receiving federal funding to conduct medical research
studies must enter into a contractual agreement with the federal government, called an assurance, 77 asserting that they will comply with the
Common Rule. 78 Once an institution’s assurance is approved and it
receives federal funding, the federal government requires that all research conducted by the institution regardless of who funds it comply
with 45 C.F.R. Part 46. 79 The Office for Human Research Protections
(OHRP), a federal agency housed within HHS, is responsible for ensuring that institutions comply with their assurances. 80 To fulfill this
task, OHRP may request additional information in writing, conduct
telephone interviews, or conduct site visits. 81 These visits can be random
or in response to allegations of noncompliance with the Common Rule. 82

74.

45 C.F.R. § 46.111 (2015).

75.

Id.; The Office for Human Research Protections (OHRP) Guidebook concerning medical research studies adds minorities to the list of vulnerable
populations. See U.S. Dep’t of Health & Human Servs., Office for
Human Research Prots., Institutional Review Board Guidebook
(1993), https://archive.hhs.gov/ohrp/irb/irb_chapter6ii.htm#g10 [https://
perma.cc/TZ97-R6U8].

76.

Coleman et al., supra note 45, at 107.

77.

There are several types of assurances. See generally Lori A. Alvino, Who’s
Watching the Watchdogs? Responding to the Erosion of Research Ethics by
Enforcing Promises, 103 Colum. L. Rev. 893, 899–900 (2003) (discussing
Single Project Assurances, Multiple Project Assurances, and Cooperative
Project Assurances, and how those assurances must be replaced by Federal
Wide Assurances when they expire).

78.

45 C.F.R. § 46.103 (2015).

79.

Id.

80.

Id.

81.

Coleman et al., supra note 45, at 136–37; Memorandum from Director,
OHRP, to OHRP Staff, Regarding Compliance Oversight Procedures (Dec.
4, 2000), in The Ethics and Regulations of Research with Human
Subjects 138, 141 (2005) [hereinafter OHRP Memorandum].

82.

Coleman et al., supra note 45, at 136–37. For government funded medical
research studies in which there has been an allegation of noncompliance,
OHRP initiates an investigation. Id. at 140–41 (detailing the sequence of
events in compliance investigations).
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When reviewing allegations of noncompliance, OHRP grants the
institution an opportunity to refute the allegations. 83 Once additional
information is obtained, OHRP determines whether the institution has
violated the law. 84 OHRP issues corrective action for instances of noncompliance, which is in “the best interests of human research subjects,
and to the extent possible, the institution, the research community, and
HHS.” 85 Corrective action may include restriction or withdrawal of approval for an institution’s assurance and suspension or permanent removal from participation in specific projects. 86 Information regarding
allegations and findings of noncompliance can be found on OHRP’s
website. 87
OHRP is responsible for reviewing compliance at the institutional
level. 88 Every institution that has an assurance with OHRP is responsible for ensuring that individual medical research studies conducted by

83.

OHRP Memorandum, supra note 81, at 139.

84.

Id. at 141.

85.

Id.

86.

Id. at 140. Many, including the former Secretary of HHS, have argued that
OHRP has failed to issue meaningful sanctions. See L. Song Richardson,
When Human Experimentation Is Criminal, 99 J. Crim. L. & Criminology
89, 124–26 (2009) (discussing how institutions that are supposed to police
research fail to deter unethical conduct because of their reliance on selfpolicing); Donna Shalala, Protecting Research Subjects—What Must Be
Done, 343 New Eng. J. Med. 808 (2000) (arguing for a strengthening of the
regulatory system protecting human research subjects). One form of sanction
the OHRP imposes is posting a letter of violation on its website. OHRP
Memorandum, supra note 81, at 141. See generally OHRP Determination
Letters, HHS.gov, http://www.hhs.gov/ohrp/compliance-and-reporting/
determination-letters/index.html [https://perma.cc/9C4X-KR8V] (exhibiting
a searchable database of OHRP determination letters). However, in the past
when the public pressure has become too much, some institutions have
voluntarily stopped the research studies, while others have continued the
research studies. See generally David B. Resnik, Research Ethics Timeline,
Nat’l Insts. Of Health, http://www.niehs.nih.gov/research/resources/
bioethics/timeline/ [https://perma.cc/LX68-JKNP] (last updated Feb. 13,
2017) (identifying 1972 as the year “the national media and Congress [began]
focus[ing] on unethical research practices with human subjects, including the
Tuskegee study”). Yet, this is an erratic outcome that simply depends on how
much media attention the study received. See id. (providing a timeline that
suggests unethical research studies have persisted despite greater national
attention and media scrutiny).

87.

Office for Human Research Protections, https://www.hhs.gov/ohrp/
[https://perma.cc/R5ZV-EGNV] (last visited Feb. 19, 2017).

88.

Compliance and Reporting, Off. for Human Research Prots., https://
www.hhs.gov/ohrp/compliance-and-reporting/index.html [https://perma.cc/
TX6U-QPKS] (last visited Mar. 11, 2017).
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those affiliated with the institution comply with the Common Rule. 89
To accomplish this task, all institutions and federal agencies that enter
into an assurance with OHRP have an Institutional Review Board
(IRB). 90 There are an estimated 3,000 to 5,000 IRBs, which serve as the
main protection for vulnerable populations in medical research
studies. 91
Before researchers can be funded by the United States government
or conduct medical research studies using human subjects in the United
States, they must submit a research protocol to their IRB. 92 A complete
research protocol includes a statement of compliance with the ethical
principles, including the Justice Principle. 93 The IRB reviews all written
research protocols in application for medical research studies using
human subjects to ensure that the proposed studies are ethical. 94 If the
IRB finds that the research protocol is ethical, they can approve the
research to be conducted and/or submitted for funding to the United
States government. 95 The IRB can also require modifications in the research protocol or disapprove any research protocol. 96
In terms of the Justice Principle, the IRB is required to ensure that
the “[r]isks to subjects are minimized: (i) [b]y using procedures which
are consistent with sound research design and which do not unnecessarily expose subjects to risk,” 97 and the “[s]election of subjects is equitable.” 98 This section prohibits the exploitation of vulnerable populations, which is the use of vulnerable populations for medical research
studies that vulnerable populations will not benefit from, while the rest
of society act as free riders reaping the benefits without sacrifice. 99 If
89.

45 C.F.R. § 46.101(a)(2) (2015).

90.

IRBs and Assurances, Off. for Human Research Prots., https://www
.hhs.gov/ohrp/irbs-and-assurances.html [https://perma.cc/GNT3-8P3P] (last
visited Mar. 11, 2017)

91.

Alison Wichman, Institutional Review Boards, in Principles and Practice
of Clinical Research 47, 56 (John I. Gallin & Frederick P. Ognibene
eds., 2007).

92.

45 C.F.R. § 46.101(a)(2) (2015).

93.

Id. § 46.103(b)(1).

94.

Id.

95.

Id. § 46.103(a).

96.

See 10 C.F.R. § 745.101 (2015) (defining the scope of IRB policy for research
with human subjects); 28 C.F.R. § 46.101 (2015) (same); 28 C.F.R. § 46.109(a)
(2015) (stating that an IRB can approve, disapprove, or require modification
of research).

97.

45 C.F.R. § 46.111(a)(1) (2015) (emphasis added).

98.

Id. § 46.111(a)(3) (emphasis added).

99.

Id.
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the IRB fails to ensure that vulnerable populations are not exploited,
then OHRP may issue a corrective action. 100
In 1990, there was a paradigm shift in the use of the Justice Principle, which has allowed researchers to exploit economically disadvantaged minority children. 101 Specifically, instead of using the Justice Principle to protect economically disadvantaged minority children from
exploitation, now researchers use the Justice Principle to include economically disadvantaged minority children in medical research studies
that not only unnecessarily exposing them to risks, causing harm, but
also failed to provide a benefit to the population from which they originated. 102

II. Inclusion, Exploitation, and Bias
In the 1990s, Congress passed laws to ensure that a number of populations (women, minorities, children, and the economically disadvantaged), who were perceived as being left out of medical research, were
included in medical research studies. 103 Participating in medical
research studies provides economically disadvantaged minority
children, who are research subjects, with access to health care during
the study. 104 However, because of structural and institutional racial
biases that limit access to health care to those who can pay,
economically disadvantaged minority children’s access to health care
100. OHRP Memorandum, supra note 81, at 139–40.
101. See Michael I. Shevell, Ethics of Clinical Research in Children, 9 Seminars
in Pediatric Neurology 46, 48 (2002) (discussing the effect of the
adoption of guidelines in 1991).
102. See generally id. at 51 (2002) (discussing the tensions in the Justice Principle
between including vulnerable populations and excluding vulnerable populations); Levine, supra note 1, at 116 (discussing how research involving sick
children presents particularly difficult situations for investigators).
103. In 1993, Congress enacted the NIH Revitalization Act to increase female and
minority participation in medical research studies and in 1997, Congress
passed the Food and Drug Administration Modernization Act to incentivize
pharmaceutical companies to conduct medical research on children by providing an additional six months of patent exclusivity to the company even if
the results from the medical research studies were negative or inconclusive.
National Institutes of Health Revitalization Act of 1993, Pub. L. No. 103-43,
§ 206, 107 Stat. 122, 148 (codified as amended at 42 U.S.C. § 282(h) (1994));
Food and Drug Administration Modernization Act of 1997, Pub. L. No. 10515, § 111, 111 Stat. 2296, 2305–09 (codified as amended at 21 U.S.C. § 355a
(2000)); see also Ross, supra note 20, at 48–50 (providing data on the use
of child subjects in research).
104. See NIH Clinical Research Trials and You, Nat’l Insts. of Health,
https://www.nih.gov/health-information/nih-clinical-research-trials-you/
basics#1 [https://perma.cc/F9E5-5JU5] (last visited Mar. 21, 2017) (discussing how a benefit to participating in research is medical care).
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ends once the medical research study ends. As a result, economically
disadvantaged minority children are being exploited in medical research
studies, since the population from which they originate will not benefit
from the research because they lack access to health care and the
research unnecessarily exposes them to risk. 105 Inclusion without a
benefit is exploitation, which is a violation of the Justice Principle.
A. Inclusion

The Justice Principle was only in effect for a few years when the
federal government shifted its definition from protection of vulnerable
populations to inclusion of vulnerable populations to promote greater
access to medical research studies. 106 This shift in meaning was a result
of the Human Immunodeficiency Virus and the Acquired Immune Deficiency Syndrome (HIV/AIDS) epidemic and the perceived lack of participation of economically disadvantaged minority children in medical
research studies. 107
As Carol Levine notes, medical research studies became synonymous with treatment during the HIV/AIDS epidemic. 108 Due to the
HIV/AIDS crisis, people were dying with no hope for treatment. New
HIV/AIDS drugs and therapies were being tested in medical research
studies, but not available to the general public. 109 Thus, HIV/AIDS
medical research was viewed as “cutting-edge medical treatment” not
“experimental research” that could cause serious harm. 110 Consequently,
some HIV/AIDS activists began to argue that medical research “served
as an important means of access to otherwise unobtainable and theoretically helpful new therapies.” 111
Because in the 1990s the HIV/AIDS disease disproportionately affected vulnerable populations allegedly protected from the harms of
medical research (women, minorities, and children), these vulnerable

105. See Washington, supra note 2, at 271–98 (discussing research targeting
black children).
106. Ross, supra note 20, at 24.
107. Yearby, supra note 15, at 23. It was also a result of the belief that children
were therapeutic orphans. Id.
108. Levine, supra note 1, at 108–09 (describing demands by individuals suffering
from AIDS to participate in clinical drug trials with the hope of receiving a
benefit).
109. Sheryl L. Buske, Foster Children and Pediatric Clinical Trials: Access
Without Protection is Not Enough, 14 Va. J. Soc. Pol’y & L. 253, 270
(2007).
110. Id. at 271.
111. Steven Epstein, Inclusion: The Politics of Difference in Medical
Research 63 (2007) (emphasis added).
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populations, civil rights organizations, physicians, and researchers advocated for vulnerable populations’ right to participate in medical research studies to gain access to potentially life-saving treatment. 112 The
argument for the need for inclusion was further bolstered by media
reports that minorities and children lacked access to HIV/AIDS drug
studies.
For example, using National Institutes of Health (NIH) documents,
a reporter noted in a front page Los Angeles Times article that African
Americans, Latinos, and groups disproportionately afflicted with
HIV/AIDS were significantly underrepresented in federally funded
HIV/AIDS medical research studies. 113 Advocates of inclusion also
argued that children with HIV/AIDS in the United States did not
receive AZT until three years after adults gained access to AZT because
children were denied participation in medical research studies as a
result of the Justice Principle. 114
This theory of inclusion is based on an incorrect assumption that
economically disadvantaged minority children were not participating in
medical research studies, including those related to HIV/AIDS. However, as discussed below, even once the Justice Principle was adopted
in 1979, economically disadvantaged minority children were participating in medical research studies.
B. Using Inclusion to Exploit

In the late 1980s, researchers in Los Angeles gave healthy African
American infants five hundred times the approved dose of an experimental measles vaccine, which had already sickened and killed children
in Senegal, Mexico, and Guinea-Bissau. 115 This medical research study
failed to provide any benefit to the population from which the subjects
originated and unnecessarily exposed children to a risk researchers knew
was harmful. 116
As discussed in Section I.A., in the 1990s, Kennedy Krieger Institute researchers investigating cheaper lead abate techniques partnered
with landlords to partially abate lead tainted housing in Baltimore.117
112. Levine, supra note 1, at 109.
113. Epstein, supra note 111, at 61 (citing Robert Steinbrook, AIDS Trials Shortchange Minorities and Drug Users, L.A. Times (Sept. 25, 1989), https://
articles.latimes.com/1989-09-25/news/mn-175_1_aids-clinical-trials [https://
perma.cc/S6YT-FXVT]).
114. Id. at 63.
115. Washington, supra note 2, at 295.
116. See id. (explaining that the vaccine was administered after the researches
knew it would serve no benefit to the children because of the prior experimental deaths in other countries).
117. Grimes v. Kennedy Krieger Inst., Inc., 782 A.2d 807, 811–18 (Md. 2001).

1192

Case Western Reserve Law Review·Volume 67·Issue 4·2017
Exploitation in Medial Research

In order to test the efficacy of the abatement procedures, the researchers
in collaboration with the landlords ensured that only families with
healthy children lived in the lead tainted housing by agreeing to pay for
lead abatement procedures if the landlords rented to families with
young children. 118 Due to the socioeconomic status and racial makeup
of the neighborhood, the young children participating in the study were
all economically disadvantaged minorities. 119
Even though the information given to parents “implied that the
study was protecting their children from lead damage and promised to
inform parents of any hazards,” 120 such as abnormal tests showing high
lead levels, the study was non-therapeutic because it provided no benefit to the participants. 121 In fact, contrary to their promise, the researchers did not notify the parents of their children’s elevated lead
levels or lead hot spots in the house, so that the parents could protect
their children from lead exposure. 122 As a result, many of the healthy
children suffered exposure to lead, which can cause inattention, irritability, hyperactivity, learning and reading delays, delayed growth and
hearing loss, permanent brain damage, and even death. 123 Thus, this
study did not provide a benefit to the population from which the subjects originated and unnecessarily exposed children to a risk researchers
knew was harmful.
From 1992 to 1997, researchers at the Columbia University’s
Lowenstein Center for the Study and Prevention of Childhood
Disruptive Behavior Disorders and New York City’s New York State
Psychiatric Institute conducted research to try to show a link between
genetics and violence, including only African American and Latino children as subjects. 124 The researchers administered fenfluramine to 126
boys between the ages of six and ten, even though the drug had already
been shown to cause heart-valve damages, pulmonary hypertension (a
life threatening form of high blood pressure), brain damage, and death
in adults, unnecessarily exposing children to a risk researchers knew
was harmful. 125
As a result of their inclusion in the study, the children were exposed
to the same risks of physical harm the adults suffered who were pre-

118. Id. at 811–12.
119. Id. at 812.
120. Washington, supra note 2, at 292.
121. Grimes, 782 A.2d at 811–12 n.2.
122. Id. at 825.
123. Lead Exposure in Children, supra note 32.
124. Washington, supra note 2, at 272.
125. Id. at 272–75.
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viously administered fenfluramine, including but not limited to “anxiety, fatigue, headache, lightheadedness, difficulty concentrating, visual impairment, diarrhea, and nausea.” 126 No generalizable knowledge
was obtained from this study because the premise of the research that
genetics was linked with violence had been disproven by over a century
of research, and thus, the research was not using procedures that were
consistent with sound research design. 127 Furthermore, the researchers’
use of only minorities in the study, even though Caucasians also commit
acts of violence, sent the message that minorities are more violent than
Caucasians and thus must be studied. 128 Hence, the research exploited
the children for a medical research study that unnecessarily exposed
children to a risk researchers knew was harmful, unfairly labeled them
as more violent than Caucasians, and provided no generalizable knowledge because the procedures that were used were not consistent with
sound research design.
These studies are not outliers. In fact, Harriet Washington’s seminal book, Medical Apartheid, shows that economically disadvantaged
minority children have still been exploited in medical research studies
after the creation and implementation of the Justice Principle. 129 Even
when included in medical research studies conducted to find drugs for
use in children, many economically disadvantaged children are still used
for medical research studies that unnecessarily exposed children to a
risk researchers knew was harmful and provided no benefit for the population from which they originate.
For instance, for thirteen years (1988–2001), Illinois, Louisiana,
Maryland, New York, North Carolina, Colorado, and Texas enrolled
foster children between the age of three months to nineteen years old
in Phase I and II drug studies for the treatment of the HIV/AIDS.130
The majority of the foster children used for the study were economically
disadvantaged minorities. 131 The studies were conducted to determine
126. Id. at 275.
127. Id. at 275–76.
128. Id. at 277–78.
129. Id. at 236–37, 284, 294–95.
130. John Solomon, Government Tested AIDS Drugs on Foster Kids, NBC News
(May 4, 2005, 5:30 PM), http://www.nbcnews.com/id/7736157/ns/healthaids/t/government-tested-aids-drugs-foster-kids/#.WKe29RLaeT8 [https://
perma.cc/6UQG-NH45]. The medical research tested various different drugs
including protease inhibitors, Ritonavir therapy, and the live-attenuated
Varicella vaccine. See Letter from Karen Cooper, Compliance Oversight
Coordinator, Office for Human Research Prots., to Harvey R. Colten, Vice
President and Senior Assoc. Dean, Columbia Univ. Medical Ctr., and Laura
L. Forese, Vice President and Chief Medical Officer, N.Y. Presbyterian Hosp.
(May 23, 2005) (on file with author) (describing findings of the OHRP review).
131. Solomon, supra note 130.

1194

Case Western Reserve Law Review·Volume 67·Issue 4·2017
Exploitation in Medial Research

the drug toxicity and adverse side effects of drugs that had not been
shown to be safe in adults. 132 Advocates of the research have argued
that the inclusion of these children in the research benefited economically disadvantaged minority children by increasing their access to new
and effective HIV/AIDS drugs. 133 Notwithstanding this assertion,
OHRP investigated the use of economically disadvantaged minority
children in these HIV/AIDS drug studies and found that their use in
many of these studies was inequitable and violated the Justice Principle. 134
Seventeen years after the HIV/AIDS drugs studies started, OHRP
issued a letter to the head of the IRB at Columbia University Medical
Center, noting that some of the HIV/AIDS drug studies conducted at
Columbia University Medical Center violated the law. 135 Specifically,
the IRB approved research protocols in which researchers had inequitably used economically disadvantaged minority children in foster care
to participate in the studies. In 2006, OHRP sent letters of violation to
eighteen other universities conducting HIV/AIDS drug studies. 136 Each
132. Id.
133. See Levine, supra note 1, at 117 (noting that “[b]ecause many of the potential
child subjects for HIV/AIDS research are in foster care, their opportunities for
participation have been severely limited by the lack of state or agency policies and the reluctance of agency officials to approve the entry of children
into trials”).
134. Letter from Karen Cooper, supra note 130. There was also an issue of targeting
the children because of their manipulability and compromised position. See
Yearby, supra note 15, at 30 n.155 (“In addition to this subjection of
economically disadvantaged minority children to hazardous drug trials, some
researchers failed to obtain proper consent from participa[nts] in the trials.
There were two common practices that violated the informed consent laws.
First, five children participating in the New York drug trials between five
and ten years of age were asked to sign consent forms once they were told of
the risks and benefits. Second, many of the researchers failed to obtain consent from an authorized person, such as an independent advocate, for each
child. The only consent that researchers obtained for participating foster children were blanket consents from child welfare agencies. None of the 200 Illinois
foster children were appointed independent monitors even though researchers
signed a document guaranteeing ‘the appointment of an advocate for each
individual ward participating in the respective medical research.’ In New York,
monitors were only appointed to one-third of the 465 foster children participating in the medical research studies.”) (quoting Solomon, supra note 130).
135. Letter from Karen Cooper, supra note 130.
136. See, e.g., Letter from Julia Gorey, Div. of Compliance Oversight, Office of
Human Ressearch Prots., to Ronald R. Peterson, President of Johns
Hopkins/Johns Hopkins Health Sys. (Feb. 17, 2006) (on file with author)
(explaining the indicators of the university’s “noncompliance with [HHS]
regulations for the protection of human research subjects,” with reference to
certain research projects). The following institutions received similar letters
determining that they had selected foster children inequitably: Bellevue
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letter noted that the universities had used economically disadvantaged
minority foster children in violation of the Justice Principle and 45
C.F.R. § 46.111(a)(3). 137
Nevertheless, OHRP did not put an end to the studies, did not
impose any sanctions, and its findings failed to directly address the
actions of the researchers who violated the Justice Principle. 138 Consequently, the researchers who conducted the studies were able to publish
their findings in main medical journals without repercussion. In issuing
its findings, OHRP did not even explain why they found that the studies using economically disadvantaged minority children as research
subjects violated the Justice Principle, but I suggest several reasons.
First, it was not clear at the time of the studies that minority foster
children were one of the populations suffering from HIV/AIDS. 139 Thus,
participation in the studies was not a benefit to the population. In fact,
the minority foster children included in the HIV/AIDS drug studies
were not even adequately tested for HIV/AIDS. 140 The States gave blanket consent for the use of these children instead of reviewing the files
of each child to see if the child was infected with HIV/AIDS. 141 Thus,
Hospital Center, Bronx-Lebanon Hospital Center, Children’s Hospital Association, Children’s Hospital of King’s Daughters, Children’s Hospital of Philadelphia, Children’s Hospital and Research Center at Oakland, Children’s
Hospital and Regional Medical Center, Columbia University Medical Center,
Cook County Bureau of Health Services, Drexel University College of Medicine, Duke University School of Medicine, SUNY Health Science Center,
Stony Brook, SUNY Upstate Medical University, Universidad Central del
Caribe, University of Chicago, University of Maryland Baltimore School of
Medicine, University of Medicine and Dentistry of New Jersey, and University
of Miami. See Letters from the Office for Human Research Prots. (on file
with author).
137. See supra note 136 and accompanying text.
138. Id.
139. Letter from Vera Hassner Sharav, President, Alliance for Human Research
Prot., to Dr. Michael Carome, Chief of Compliance, Office of Human Research Prots., David Horowitz, Dir., Office of Compliance, Food & Drug
Admin. (Mar. 10 2004), http://ahrp.org/complaint-phase-i-aids-drugvaccineexperiment-on-foster-children/ [https://perma.cc/G2JH-2B4R].
140. Solomon, supra note 130; see also Sharav, supra note 139 (explaining that a
false positive is possible in young infants with HIV-positive mothers because
“in the uninfected infant, passively acquired maternal lgG antibodies disappear
on average in 7 to 10 months, but may occasionally persist until 18 months.
Therefore, a positive HIV antibody test in the young infant merely confirms
maternal HIV infection but is not diagnostic for HIV infection specific to the
infant.” (citing New York State Department of Health (DOH), Clinical Care
of Adolescents and Children with HIV Infection: HIV Testing and Diagnosis,
Hivdent, http://www.hivdent.org/_pediatrics_/dohdoh11/1section1iii.htm
[https://perma.cc/YJP6-23YY] (last visited Apr. 27, 2017))).
141. Sharav, supra note 139.
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it can be argued that the children were selected simply “because of their
easy availability, their compromised position, or their manipulability,
rather than for reasons directly related to the problem being studied.”142
Second, the children were public wards and according to the Justice
Principle, researchers are not allowed to use the economically disadvantaged, who rely on public funds for health care, to be used as research subjects for publicly funded research because they are already
overburdened and unlikely to benefit as a population from the research. 143
Third, the healthy children were unnecessarily “exposed . . . to the
risks of medical research and drugs that were known to have serious
side effects in adults and for which the safety for children was unknown.” 144 The drugs tested were failed cancer drugs that had severe
side effects including “rashes, vomiting and sharp drops in infectionfighting blood cells,” and death. 145 Hence, yet again, healthy minority
children were subjected to unnecessary risks that researchers knew were
harmful.
The dangers of participation in these studies for healthy children
are best illustrated by an Illinois study of dapsone, a drug to prevent
AIDS-related pneumonia. 146 “Researchers reported that some children
had to be taken off the drug because of ‘serious toxicity,’ others developed rashes, and the rates of death and blood toxicity were significantly
higher in children who took the medicine daily, rather than weekly.”147
The researchers noted that for the period of the study “[a]t least 10
children died from a variety of causes, including four from blood poisoning, and researchers said they were unable to determine a safe, useful
dosage. They said the deaths didn’t appear to be ‘directly attributable’
to dapsone but nonetheless were ‘disturbing.’” 148
Finally, research shows that not only did some of these healthy
children experience long-term disability or die as a result of their participation in these studies, 149 but also it shows that many economically
disadvantaged minority children in the United States still do not have
142. Belmont Report, supra note 5, at 23,194.
143. Id. at 23,196–97.
144. Solomon, supra note 130.
145. Id.
146. Id.
147. Id.
148. Id. (emphasis added). This was not the only clinical trial in which death was
a side effect of the drugs. “In one study, researchers reported a ‘disturbing’
higher death rate among children who took higher doses of a drug. That
study was unable to determine a safe and effective dosage.” Id.
149. Id.
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access to this medicine. 150 The studies did not provide a benefit to economically disadvantaged children because structural and institutional
racial biases limit their access to health care and medicine.
C. Bias in Health Care

Structural racial bias operates at the societal level, denying some
groups access to the resources of society, while privileging other
groups. 151 “Institutional [racial] bias operates through organizational
structures and establishes ‘separate and independent’ barriers through
the neutral denial of access to quality health care that results from the
normal operations of the institutions in a society.” 152 Although most
research on structural and institutional racial biases within the health
care system focuses on adults, it is clear that when these adults have
children, the biases also impact their children’s access to health care.153
I will discuss how these biases that affect adults impact their children
and where available, I will discuss research that has directly focused on
children.
1. Structural Racial Bias

“Structural racial bias is a result of ‘power relationships that exist
between racial and socioeconomic groups, where [one] dominant group[]
holds power over [the] other[] [group] and use[s] that power to secure
150. See Am. Acad. of Pediatrics, Comm. on Pediatric AIDS, Section on Int’l
Child Health, Policy Statement: Increasing Antiretrovial Drug Access for
Children with HIV Infection, 119 Pediatrics 838, 838–39 (2007) (explaining
that “there are numerous barriers to delivery of [Antiretroviral Therapy] to
children in resource-limited settings”); Sarah Childress, Why Some with HIV
Still Can’t Get Treatment, PBS (July 11, 2012), http://www.pbs.org/
wgbh/pages/frontline/social-issues/endgame-aids-in-black-america/whysome-with-hiv-still-cant-get-treatment/ [https://perma.cc/H8H8-TG7H] (explaining that one primary reason Americans are not receiving treatment for
HIV is that they cannot afford it).
151. Mullings & Schulz, supra note 69, at 12. See also René Bowser, Racial
Profiling in Health Care: An Institutional Analysis of Medical Treatment
Disparities, 7 Mich. J. Race & L. 79, 85 (2001) (finding that racial bias
causes “racial disparities [to] exist across a spectrum of health care settings
and cover[s] a host of diseases”).
152. Ruqaiijah Yearby, Racial Disparities in Health Status and Accessing Health
Care, in Debates on U.S. Healthcare 78, 83 (Jennie Jacobs Kronenfeld
et al. eds., 2012).
153. Children’s Health Disparities are not often studied, which is why Ivor Braden
Horn of the Children’s National Medical Center and Anne C. Beal of The
Commonwealth Fund wrote an article calling for the framing of a research
agenda for studying child health disparities. See generally Ivor B. Horn &
Anne C. Beal, Child Health Disparities: Framing a Research Agenda, 4
Ambulatory Pediatrics 269 (2004) (providing a framework for research
on child health care disparities).
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material and social resources such as income [and] wealth.’” 154 The
dominant group remains in power “because [its] position in society enables [it to retain power] despite the will or aims of [the groups it] has
power over.” 155 In health care, structural bias is the delivery of health
care based on ability to pay.
As a result of this bias, “those with privilege, such as wealthy Caucasians, . . . obtain the best quality health care available.” 156 The
privileged obtain access because they are able to afford health insurance
or pay for health care not covered by insurance. Those without privilege, such as minorities and the economically disadvantaged, have limited access to health care because they do not have health insurance or
they cannot afford to pay for health care. 157 For instance, “African Americans and Hispanics are more likely than Caucasians to work in lowwage jobs, and tend to have reduced access to employer-sponsored coverage relative to their higher-wage counterparts.” 158 This directly affects
the health care of African American and Hispanic children.
For example, most union-represented housekeeping, maintenance,
and other service workers at the Johns Hopkins Hospital are paid under
$14.91 per hour, leaving them below the poverty level. 159 As a result of
the low pay, their children are uninsured or on Medicaid because they
cannot afford to purchase Hopkins health insurance. 160 Consequently,
minority children and adults are more likely than Caucasians to be
uninsured. This has not changed with the passage of the ACA.
In the first open enrollment period of the ACA (2013–2014), the
percentage rates of uninsured fell significantly for economically disadvantaged adults (from 35% to 24%) and Hispanics (from 36% to
23%). 161 In 2014, thirty-three million people (10.4%) were without
154. Ruqaiijah Yearby, Racial Inequities in Mortality and Access to Health Care:
The Untold Peril of Rationing Health Care in the United States, 32 J. of
Legal Med. 77, 87 (2011) (citations omitted).
155. Id.
156. Id.
157. Id. at 80.
158. Id. at 83.
159. Fern Shen, Johns Hopkins Hospital Workers Protest “Poverty Wage” Pay
Scale, Baltimore Brew (April 1, 2014), https://www.baltimorebrew
.com/2014/04/01/johns-hopkins-hospital-workers-protest-poverty-wage-payscale/ [https://perma.cc/KAC7-N6UM].
160. Id.
161. New Survey: After First ACA Enrollment Period, Uninsured Rate Dropped
from 20 Percent to 15 Percent; Largest Declines Among Young Adults,
Latinos, and Low-Income People, The Commonwealth Fund (July 10,
2014), http://www.commonwealthfund.org/publications/press-releases/2014/
jul/after-first-aca-enrollment-period [https://perma.cc/32AL-SNUW].
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health insurance. 162 In 2014, employment-based health insurance covered 55.4% of the U.S. population, Medicaid covered 19.5% of the U.S.
population, Medicare covered 16% of the U.S. population, directpurchase health care covered 14.6% of the U.S. population, and military
health care covered 4.5% of the U.S. population. 163 Nevertheless, minorities and the economically disadvantaged still remain uninsured at a
higher rate than those who are privileged because of the failure of those
in power in nineteen states to expand Medicaid coverage.
As of January 2016, Washington, DC and thirty-one states have
expanded Medicaid to cover economically disadvantaged adults. However, in the nineteen states that did not expand Medicaid, the economically disadvantaged remain without health insurance because their
employer does not provide coverage, they earn too much to qualify for
Medicaid, and they do not earn enough to qualify for tax credits to
purchase health insurance on their own. 164 Approximately three million
economically disadvantaged adults remain uninsured because of the
failure to expand Medicaid, and they reside in states with the largest
uninsured population such as Texas, Florida, Georgia, and North
Carolina. 165
More than sixty percent of the economically disadvantaged, who
are in a family with a worker, remain uninsured because of the failure
to expand Medicaid. 166 They work in part-time jobs, jobs for employers
with less than fifty employees (so not covered by the ACA penalties),
or jobs that do not provide health insurance like those in the agriculture
and service industries. 167 Because minorities are more likely to work in
these industries and live in families with lower incomes than Caucasians, they disproportionately remain uninsured due to the failure to

162. Jessica C. Smith & Carla Medalia, Health Insurance Coverage in the
United States: 2014, Current Population Reports, U.S. Census Bureau
3 (Sept. 2015), https://www.census.gov/content/dam/Census/library/
publications/2015/demo/p60-253.pdf [https://perma.cc/JWD7-G4BV].
163. Id.
164. Id.
165. Rachel Garfield & Anthony Damico, The Coverage Gap: Uninsured Poor
Adults in States that Do Not Expand Medicaid, Kaiser Family Found. 2
(Oct. 19, 2016), http://kff.org/uninsured/issue-brief/the-coverage-gapuninsured-poor-adults-in-states-that-do-not-expand-medicaid/ [https://perma
.cc/KQA5-QJ2A].
166. Id. at 4.
167. Id.
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expand Medicaid. 168 In fact, minorities make up over half of the uninsured, while only accounting for forty percent of the U.S. population. 169 This affects children as well.
Before the ACA, an estimated eight million children were uninsured. 170 The three states with the highest number of uninsured children
were Texas (21.4%), Florida (19.2%), and New Mexico (15.5%). 171 Since
the passage of the ACA, an estimated five million children remain uninsured. 172 Although the federal government partners with states under
Medicaid and the Children’s Health Insurance Plan to provide health
insurance for nearly forty percent of all economically disadvantaged
children, minority children are still more likely to be uninsured than
Caucasian children. 173 These uninsured children are more likely to live
in low-income families and almost a quarter of them are in fair or poor
health. 174 Moreover, earlier studies have shown that “uninsured children
are also more likely . . . to have gone without needed medical, dental,
or other health care . . . . [and they are] more likely to rely on the
emergency room as their usual source of care.” 175 Lack of insurance also
results in lack of access to prescription medicine. 176 A poignant example
of how structural racial bias affects economically disadvantaged children access to health care is the Deamonte Driver story.
Deamonte Driver, an African American male youth, died of a toothache because he did not have health insurance and so he never received
a routine $80 tooth extraction that may have saved him.177 Deamonte
168. Id. at 2.
169. Rachel Garfield et al., The Uninsured: A Primer, Kaiser Family Found.
9 (Nov. 2016), http://files.kff.org/attachment/Report-The-Uninsured-A%20
Primer-Key-Facts-about-Health-Insurance-and-the-Unisured-in-America-inthe-Era-of-Health-Reform [https://perma.cc/6CZB-X9MM].
170. James A. Baker III Inst. for Pub. Pol’y of Rice Univ., The Economic
Impact of Uninsured Children on America, 40 Baker Inst. Policy Rep.,
no. 40, June 2009, at 2, http://www.bakerinstitute.org/media/files/
Research/6db8160c/HPF-pub-HoShortUninsuredChildren-060309.pdf [https:
//perma.cc/493P-XSE5] [hereinafter Baker Inst. Pol’y Rep.].
171. Id.
172. Elizabeth Cornachione et al., Kaiser Comm’n on Medicaid & the
Uninsured, Children’s Health Coverage: The Role of Medicaid
and CHIP Issues for the Future 1 (2016).
173. Id. at 6.
174. Baker Inst. Pol’y Rep., supra note 170, at 4, 6.
175. Id. at 3.
176. Id.
177. Mary Otto, For Want of a Dentist Pr. George’s Boy Dies After Bacteria
from Tooth Spread to Brain, Wash. Post (Feb. 28, 2007), https://www.
washingtonpost.com/archive/local/2007/02/28/for-want-of-a-dentist-spanclassbankheadpr-georges-boy-dies-after-bacteria-from-tooth-spread-to-brain-
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Driver’s family was no different than most working poor families. His
mother worked several jobs, but none provided insurance, or paid
enough for the family to buy insurance. 178 Deamonte was covered under
Medicaid, which covers oral health services. 179 However, he never received the dental care he needed because there was a shortage of dentists
willing to treat Medicaid patients or those who cannot afford to pay for
health care. 180 By the time his mother was able to locate a dentist willing to take Medicaid, Deamonte was no longer covered by Medicaid
and thus did not receive treatment. 181
Lacking health insurance, Deamonte received all of his care in an
emergency room or hospital. 182 Instead of a tooth extraction, his care
included two brain surgeries, six weeks of hospitalization, and physical
and occupational therapy, totaling $250,000. 183 On his last day,
Deamonte played cards and watched a show on television with his mother. 184 When he called her later that evening, Deamonte said, “Make
sure you pray before you go to sleep.” 185 The next morning, Deamonte
was dead from a brain infection caused by the spread of the bacteria
from the abscess in his mouth. 186 Deamonte did not have to die; he was
only a twelve-year-old boy with a cavity. He died because health care
in the United States is provided based on ability to pay, not medical
need. Deamonte’s death is not an outlier. In fact, a research study conducted by Johns Hopkins Children’s Center found that uninsured children faced a sixty percent increased risk of dying than insured children.187
Even if economically disadvantaged minority children are covered
by Medicaid, this does not guarantee them access to medical and dental

span/34055bc4-0986-4ee1-918a-fcfb0b3b541a/ [https://perma.cc/WHF588XP].
178. Id.
179. Id.
180. Id.
181. Id.
182. Id.
183. Id.
184. Id.
185. Id.
186. Id.
187. Roni Caryn Rabin, Hospitalized Children Without Insurance are More
Likely to Die, a Study Finds, N.Y. Times (Oct. 30, 2009), https://
prescriptions.blogs.nytimes.com/2009/10/30/lacking-insurance-hospitalizedchildren-more-likely-to-die/ [https://perma.cc/AX22-U92F].
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care. Research shows that Medicaid patients have a difficult time accessing health care because Medicaid reimbursement rates are so low.188
In fact, numerous states, including California, Florida, Illinois, Massachusetts, and Texas, have been sued for failing to provide children with
early and periodic screening, diagnosis, and treatment. 189 Moreover,
when minorities and the economically disadvantaged obtain private
health insurance, they still lack access to health care because they are
underinsured, meaning they have to pay high deductibles or out of
pocket for medical costs.
According to a Commonwealth Fund report, in 2014 over thirtyone million people were underinsured, about twenty-three percent of
those with year-round health insurance. 190 Of the underinsurance, fortyfour percent reported forgoing care because of the cost, and fifty-one
percent reported having problems paying medical bills or debts, totaling
$4,000 or more. 191 People with low incomes under 200% of the federal
poverty line accounted for sixty-one percent of underinsured adults in
the U.S. 192 By 2015, the U.S. Census bureau reported that 46.2 million
people (14.7%) were in poverty in the United States. 193 The poverty
rate has increased from 2007–2011, when the U.S. Census bureau reported that 42.7 million people (14.3%) had incomes below the poverty
line. 194 The rate of poverty for African Americans was 25.8% and 23.2%
for Hispanics compared to 11.6% for Caucasians. 195
188. Elizabeth Renter, You’ve Got Medicaid: Why Can’t You See the Doctor?,
U.S. News & World Rep. (May 26, 2015), https://health.usnews.com/
health-news/health-insurance/articles/2015/05/26/youve-got-medicaid-whycant-you-see-the-doctor [https://perma.cc/3WSM-E78X].
189. O.B. v. Norwood, 170 F. Supp. 3d 1186 (N.D. Ill. 2016); Fla. Pediatric Soc’y
v. Sec’y of Fla. Agency for Health Care Admin., No. 05-23037-CIV., 2008
WL 4072805 (S.D. Fla. July 30, 2008); Katie A. v. L.A. Cnty., 481 F.3d 1150
(9th Cir. 2007); Rosie D. v. Romney, 410 F. Supp. 2d 18 (D. Mass. 2006);
Frew v. Hawkins, 540 U.S. 431 (2004).
190. Sara R. Collins et al., The Commonwealth Fund, The Problem of
Underinsurance and How Rising Deductibles Will Make It Worse
1 (2015).
191. Id.
192. Id. at 15.
193. Alemayehu Bishaw & Brian Glassman, U.S. Census Bureau,
Poverty: 2014 and 2015, at 3 (2016), https://www.census.gov/content/
dam/Census/library/publications/2016/demo/acsbr15-01.pdf [https://perma
.cc/8RZZ-X83A].
194. Suzanne Macartney et al., U.S. Census Bureau, Poverty Rates
for Selected Detailed Race and Hispanic Groups by State and
Place: 2007–2011, at 2 (2013), https://www.census.gov/prod/2013pubs/
acsbr11-17.pdf [https://perma.cc/83E6-B7CV].
195. Carmen DeNavas-Walt et al., U.S. Census Bureau, Income,
Poverty, and Health Insurance Coverage in the United States:
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Adding insult to injury, the wealthy, who predominantly have
health insurance, receive discounts on the cost of health care, negotiated
by their insurers, while minorities and the economically disadvantaged,
who do not generally have health insurance or are underinsured, are
charged more for the health care services they receive and are increasingly required to pay upfront for the care they receive. 196 Under the
ACA, 197 nonprofit hospitals can no longer charge uninsured patients
more than they generally bill insured patients for emergency and other
medically necessary care. 198 Unfortunately, this still leaves the uninsured unprotected because the policy does not apply to for-profit hospitals, which account for up to one fifth of all hospitals in the U.S.199
Additionally, it still leaves it up to the nonprofit hospital to determine
who qualifies for charity care, which as discussed in Subsection 2, the
hospital may not extend to everyone who qualifies.
Additionally, the ACA does not equalize the care provided to minorities or the economically disadvantaged when compared to the
wealthy. A 2012 New York Times article noted that affluent patients,
who pay in cash, can stay in elite hospital wings that offer marble baths,
butler service, and bed linens by “Frette, Italian purveyors of highthread-count sheets [sold] to popes and princes.” 200 Yet, the article noted that one patient who could not afford the elite rooms was left in
pain, on a gurney, without a bedpan. 201
Unequal treatment affects children as well. “[A] study of 965 children with acute asthma who were treated in emergency departments
2007 (2008), https://www.census.gov/prod/2008pubs/p60-235.pdf [https://
perma.cc/QM3C-NGRA]. This poverty was in part because of low income.
In 2007, the average African-American family median income was $33,916,
sixty-two percent of the median income for Caucasians, while the median
income for Hispanic households was $38,679, seventy percent of the median
income for Caucasians. Id. at 7.
196. Sammy Mack, They Paid How Much? How Negotiated Deals Hide Health
Care’s Cost, NPR (Nov. 15, 2014), http://www.npr.org/sections/healthshots/2014/11/15/364064088/they-paid-how-much-how-negotiated-dealshide-health-cares-cost [https://perma.cc/TS6E-DBSP].
197. Patient Protection and Affordable Care Act, 26 U.S.C. § 5000A (2012).
198. I.R.C. § 501(r)(5)(a) (2012) (outlining the limitations on charges for certain
hospitals).
199. Am. Hosp. Ass’n, Fast Facts on U.S. Hospitals (2017), http://
www.aha.org/research/rc/stat-studies/101207fastfacts%20with%20picture
%202017.pdf [https://perma.cc/AVD7-B5SQ].
200. Nina Bernstein, Chefs, Butlers, Marble Baths: Hospitals Vie for the Affluent,
N.Y. Times (Jan. 21, 2012), https://www.nytimes.com/2012/01/22/nyregion
/chefs-butlers-and-marble-baths-not-your-average-hospital-room.html [https:
//perma.cc/XK2F-N9CL].
201. Id.
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found that uninsured children consistently received lower quality of care
than insured children.” 202 Institutional bias also prevents access to
health care for these groups, because health care institutions are allowed
to decide what hospitals to close and who qualifies for charity care.
2. Institutional Racial Bias

Examples of institutional racial bias within the health care system
include hospital closures in minority neighborhoods and lawsuits against the economically disadvantaged for unpaid care. Both further
limit access to health care for economically disadvantaged minority
children. Not all actions by an institution that disproportionately affect
minorities and the economically disadvantaged are biased. In order to
constitute institutional bias, the action must reinforce the racial and/or
class hierarchy and impose substantial harm on minorities and the economically disadvantaged. Once this occurs, then the institution’s actions constitute institutional bias even if the actions are seemingly neutral. 203
Shortly after the passage of the Civil Rights Act of 1964, hospitals
in African American communities closed and relocated to affluent Caucasian neighborhoods. 204 This still continues. In 1992, a report of 190
urban community hospitals between 1980 and 1987 found that the percentage of African American residents in the neighborhood was the
most significant factor in hospital closures. 205 In 2006, Alan Sager reported that as the African American population in a neighborhood increased, the closure and relocation of hospital services increased for
every period between 1980 and 2003, except between 1990 and 1997.206
Hence, research shows that as the percentage of African American residents increases in the neighborhood, hospital closures increase.

202. Baker Inst. Pol’y Rep., supra note 170, at 3.
203. See Brietta R. Clark, Hospital Flight From Minority Communities: How Our
Existing Civil Rights Framework Fosters Racial Inequality in Healthcare, 9
DePaul J. Health Care L. 1023, 1035 (2005).
204. Beatrix Hoffman, Health Care for Some: Rights and Rationing
in the United States Since 1930, at 151 (2012).
205. David Barton Smith, Health Care Divided: Race and Healing a
Nation 200 (1999) (citing David G. Whiteis, Hospital and Community
Characteristics in Closures of Urban Hospitals, 1980–87, 107 Pub. Health
Rep. 409 (1992)).
206. See Alan Sager & Deborah Socolar, Closing Hospitals in New
York State Won’t Save Money but Will Harm Access to Health
Care 27–31, 42 app. 2 (2006), https://www.bu.edu/sph/files/2015/05/
Sager-Hospital-Closings-Short-Report-20Nov06.pdf [https://perma.cc/EZ5DNPHA] (tracking the percent of hospitals closing alongside the racial makeup
of the area).
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In fact, Dr. Sager has shown that forty-five percent of hospitals
open in 1970 had closed by 2010, and of these hospitals sixty percent
were in neighborhoods that were predominately African American.207
St. Louis and Detroit are poignant examples of these race-based hospital closures. St. Louis had eighteen hospitals in predominately African
American neighborhoods. By 2010, all but one had closed. 208 In 1960,
Detroit had forty-two hospitals open in predominately African American neighborhoods; by 2010 only four were open.209
This reduction of hospital beds in African American communities,
which generally have the greatest need for care, further compromises
African Americans’ health by decreasing their access to health care
thereby increasing health care costs. 210 As hospitals leave predominately
African American neighborhoods, the remaining hospitals are left to fill
the void. This often strains the remaining hospitals’ resources and their
ability to provide quality care. Consequently, the hospitals that do
remain to provide care to African Americans gradually deteriorate and
provide substandard care. 211
Not only is access to health care diminished because of a reduction
of hospital services, but care also suffers because of physician
departures. 212 Once a hospital has closed or relocated, the physicians
practicing in the area often follow the hospital to more affluent neighborhoods, thereby further disrupting the health care services in predominately African American neighborhoods. 213 Evidence shows that
primary care physicians often leave after the closure of a neighborhood
hospital because the hospital provides a critical base for their
practice. 214 This disruption in care is significant because many
predominately African American neighborhoods already suffer from
physician shortages prior to hospital closures and physician flight. 215 As
the number of primary care physicians decreases, African Americans
207. Alan Sager, Professor of Health Policy & Mgmt., Bos. Univ. Sch. Of Pub.
Health, Urban Hospital Closings: Why Care? What to Do? Policy and Financial Remedies for a Race-linked Health Problem at Case Western Reserve
University Law-Medicine Symposium (Mar. 28, 2014).
208. Id.
209. Id.
210. See Clark, supra note 203, at 1035 (“Hospital closures set into motion a chain
of events that threaten minority communities’ immediate and long term
access to primary care, emergency and nonemergency hospital care . . . .”).
211. Id. at 1034–35.
212. Id. at 1034.
213. Id. at 1033.
214. Id.
215. Gwendolyn Roberts Majette, Access to Health Care: What a Difference
Shades of Color Make, 12 Annals Health L. 121, 130 (2003).
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are forced to seek care in emergency rooms and public hospitals, which
are often understaffed and not adequately maintained. 216 Thus, the
institutional decision to close hospitals in predominately African
American neighborhoods substantially harms African Americans and
reinforces the racial hierarchy that African American lives do not
matter.
In addition to the lack of health care services available in minority
neighborhoods, some nonprofit hospitals erect barriers to care for the
economically disadvantaged by suing them for unpaid medical bills.217
These practices have continued even after the passage of the ACA,
which tried to limit these aggressive collection practices. 218 Numerous
nonprofit hospitals in Ohio, Minnesota, Missouri, New York, North
Carolina, and Texas, have sued patients for unpaid bills, even though
many of the patients are economically disadvantaged and could qualify
for charity care, which would discharge their bills. 219
For example, in North Carolina, nonprofit hospitals have filed more
than 40,000 collection lawsuits in a five-year period. 220 Carolinas
HealthCare system, a nonprofit health care system, has filed over 12,000
lawsuits in a five-year period, while having over $150 million in annual
profits and enjoying $100 million in tax breaks. 221 Many of the patients
who were sued for unpaid bills were uninsured and were economically

216. Clark, supra note 203, at 1035.
217. Ames Alexander & David Raynor, Charlotte Hospital System Sues Thousands
of Patients, News & Observer (Apr. 24, 2012), http://www.newsobserver
.com/news/special-reports/prognosis-profits/article16924670.html [https://
perma.cc/VWZ4-FMAC].
218. Ames Alexander, Carolinas HealthCare Sues, Despite New Laws, The
Charlotte Observer (Feb. 21, 2015), http://www.charlotteobserver.com/
news/local/article10708520.html [https://perma.cc/A6TV-AF7V].
219. See Dianna Wray, Memorial Hermann Continues to Sue the Uninsured for
Charges They Can’t Afford, Houston Press (May 26, 2015), http://www.
houstonpress.com/news/memorial-hermann-continues-to-sue-the-uninsuredfor-charges-they-cant-afford-7456492 [https://perma.cc/948B-EQ9N]; Jenny
Gold, Sued Over An $1,800 Hospital Bill, Kaiser Health News (Apr. 27,
2012), http://khn.org/news/charity-care-nonprofit-hospitals-patient-debt/
[https://perma.cc/E85D-RR7R]; Jeffrey Young, North Carolina Hospitals
Sued 40,000 Patients Over Unpaid Bills, Huffington Post (Apr. 27, 2012),
http://www.huffingtonpost.com/2012/04/27/north-carolina-hospitals-debtcollection_n_1459324.html [https://perma.cc/KYF5-RPXJ]; Chris Arnold
& Paul Kiel, When Nonprofit Hospitals Sue Their Poorest Patients, NPR
(Dec. 19, 2014), https://www.npr.org/2014/12/19/371202059/when-ahospital-bill-becomes-a-decade-long-pay-cut [https://perma.cc/CU48-5YA9].
220. Alexander & Raynor, supra note 217.
221. Id.
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disadvantaged. 222 Once the hospital wins the case and receives a judgment against the patient, it usually places a lien on the patient’s
house. 223 Due to the lawsuits, the economically disadvantaged patients
cannot sell their homes, are pushed further below the poverty line, have
their credit report scores decline, and forgo medical care because they
are worried about future wage garnishments and liens being placed on
their homes. This substantially harms them and reinforces the class
hierarchy that the lives of the economically disadvantaged do not
matter.
Due to structural and institutional racial biases within the health
care system, minorities and the economically disadvantaged lack access
to medicine and health care because they are uninsured, underinsured,
or unable to pay for health care. As a result of forgoing health care,
minorities and the economically disadvantaged are often more likely to
be disabled or in poor health and vulnerable to inducements to participate in medical research to obtain access to health care. However, because of structural and institutional racial biases, once the medical research studies end, minorities and the economically disadvantaged do
not receive the benefit of the studies because they cannot afford the
medicine and lack access to health care.
D. The Effect of Bias on Medical Research

Researchers from health care institutions that deny minorities and
the economically disadvantaged access to health care use these same
populations as subjects for medical research studies. In fact, empirical
data shows that in comparison with their percentage in the U.S. census,
African American children continue to be overrepresented in nontherapeutic medical research studies and underrepresented in Phase III
therapeutic medical research studies. 224
This means that when compared to Caucasians, African American
children participate in medical research studies that may or may not
add to scientific knowledge that benefits the general society, but not in
medical research studies that will be beneficial for them as a group. The
literature suggests that the reason for this overrepresentation in nontherapeutic medical research studies is that African American children
are overrepresented in economically disadvantaged neighborhoods,
which house the academic medical centers that conduct medical research studies. 225 Thus, African American children are included in medical research studies because of their proximity to the academic medical
222. Id.
223. Id.
224. Ross, supra note 20, at 48–50.
225. Id. at 51–53. However, this still does not explain why African American
children are not represented in Phase III therapeutic medical research studies
conducted by academic medical centers in which treatment is a goal.
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centers, not because the research addresses their populations’ health
needs. Researchers who conduct medical research studies using economically disadvantaged minority children are often affiliated with health
care institutions that prevent access to health care for economically
disadvantaged minority children.
Although there is little research regarding how institutional decisions affect children’s access to health care, it is clear that institutional
decisions limit access to health care for the economically disadvantaged
and minority adults. This can have an indirect effect on children if the
patients denied care are their parents. For example, Heartland Regional
Medical Center, a nonprofit hospital in Missouri that receives tax
breaks in exchange for providing care to the economically disadvantaged, has sued approximately 6,000 patients for unpaid bills from 2009–
2013, even though some of the patients should have qualified to have
their bills forgiven. 226 Once the hospital wins the case and receives a
judgment against the patient, it is allowed to garnish the patient’s
wages—and if the state allows it, the hospital can also charge the patient interest on her bill. 227
The hospital has also taken liens out on a patient’s home to recoup
the costs of any judgments exceeding $1,000. 228 In 2013, the hospital
made $605 million in gross revenues, $45 million of which was profit,
yet it filed over 2,200 lawsuits for medical debts. 229 Garnishments
amount to one-half of one percent of the hospital’s revenues. 230 As a
result of these institutionally biased practices, many economically disadvantaged patients cannot sell their homes, are pushed further below
the poverty line, have their credit report scores decline, and forgo medical care for themselves and their children because they are worried
about future wage garnishments and liens being placed on their homes.
Notwithstanding the lawsuits filed to collect unpaid hospital bills from
the uninsured and economically disadvantaged, Heartland Regional
Medical Center recruits some of these patients to participate in the
medical research studies, which offer access to free health care only
when the subject is participating in the medical research study.
In addition to the financial barriers to care, many hospitals refuse
to treat certain uninsured and economically disadvantaged patients,
often redirecting them to community hospitals or clinics, while using

226. Arnold & Kiel, supra note 219.
227. Id. (describing how Heartland sued both adults in a household and garnished
their wages, one at ten percent and the other at twenty-five percent, and
also charged the patient nine percent interest on the bill).
228. Id.
229. Id.
230. Id.
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them as research subjects in medical research. The University of Chicago Medical Center (Center) is a perfect example of this tension between denying care to minorities and the economically disadvantaged,
while focusing on expanding medical research studies using these populations. In 2009, the Center adopted policies to redirect people, suffering from non-urgent injuries and illnesses, who lived in the neighborhoods surrounding the hospital, elsewhere to community hospitals
and clinics. 231 Because the hospital is located in an economically disadvantaged area that is racially segregated, the people being redirected
were disproportionately disadvantaged minorities. However, when the
Center needed subjects for research, for studies, these people were solicited for participation in research because of their proximity to the
hospital. 232
Denials of access to health care occur even when care is required.
Under the Emergency Medical Treatment and Active Labor Act
(EMTALA), 233 hospitals are required to provide a screening examination to determine if a person is experiencing an emergency condition or
in active labor. 234 If the patient is experiencing an emergency condition
or in active labor, the hospital, regardless of the patient’s ability to pay,
is required to stabilize the patient, admit the patient, or complete an
appropriate transfer to another facility. 235 Unfortunately, some hospitals
violate EMTALA by denying care to patients based on ability to pay,
but then seek to use these same patients as medical research subjects.
For instance, in 2009, the Center tried to limit the number of inpatient
beds available to emergency room patients and failed to provide care
to those with urgent care injuries. 236 Although the policies were not fully
implemented after two physician groups voiced their concerns, the hospital still failed to provide care to patients with urgent care injuries and
was fined $50,000 as a result of the death of a patient waiting in the
emergency room. 237 As discussed above, the Center still uses these people in medical research studies.
In the United States, structural and institutional racial biases prevent economically disadvantaged minorities from accessing health care
231. Kathleen Louden, Chicago Hospital to Halt New Emergency Department
Policies After Criticism, Medscape (Mar. 16, 2009), https://www.medscape
.com/viewarticle/589704 [https://perma.cc/XX3S-82ZQ].
232. Ross, supra note 20, at 51–53.
233. Emergency Medical Treatment and Active Labor Act 42 U.S.C. § 1395dd
(2012).
234. 42 U.S.C. § 1395dd(a) (2012).
235. Id. § 1395dd(b).
236. Nina Youngstrom, After Patient Death, University of Chicago Settles
EMTALA Case, AISHealth (Dec. 24, 2012), https://aishealth.com/archive
/rmc122412-05 [https://perma.cc/8HUA-LVBJ].
237. Id.
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and medicine. These biases allow institutions to bring lawsuits for unpaid care and outright deny care because health care is delivered based
on ability to pay, not need. Hence, even if economically disadvantaged
minority children participate in a medical research study that finds a
new treatment for a disease, the children will not have access to the
treatment because structural and institutional racial biases prevent
them from accessing the treatment once the study is completed. Thus,
even if researchers have good intentions when they include economically
disadvantaged minority children in medical research studies, it still may
be exploitation, a violation of the Justice Principle, because the population from which the subject originates will not benefit from the research.

III. Ensuring Justice Is Fulfilled
Although arguments for inclusion were based on altruistic notions
of providing everyone with a “fair opportunity” to participate in medical research studies to obtain access to treatment, it ignores structural
and institutional racial biases that limit economically disadvantaged
minority children’s access to health care and treatment after the medical research study ends, preventing them from benefiting from participation in medical research. In order to prevent exploitation of economically disadvantaged minority children, I suggest that the Justice Principle incorporate the Human Development Approach, which demands
that researchers provide a benefit to the population from which the
subjects originated that alleviates some of the population’s underlying
problems, such as lack of access to health care. To ensure that there is
a benefit that will alleviate some of the population’s underlying problems, I propose the use of the Vulnerability and Equity Impact Assessment (VEIA) tool, which I created based on the Health Equity Impact
Assessment (HEIA) tool. 238
Under the VEIA, the researcher must complete an introspective
summary of their research that includes the purpose of the research,
those affected by the condition being studied, whether the research is a
priority to those affected with the condition, and pinpoint any disparities (age, racial, or class based) in the treatment of the condition.
After completing this summary, researchers need to identify the structural and institutional racial biases that prevent economically disadvantaged minority children from accessing health care, the adverse
impacts economically disadvantaged minority children will suffer as a
result of their participation in the research, and whether participation
in the medical research study will alleviate structural and institutional
racial biases. If researchers determine that because of their status (age,
social class, race) economically disadvantaged minority children are

238. Haber, supra note 18.
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overburdened, then the researchers cannot use the children as research
subjects.
Using the VEIA, a newly created Board of Children (Board for
Children or the Board) would be responsible for approving all medical
research studies seeking U.S. government funding that plan to use
children. The completed tool should be posted on clinicaltrials.gov and
used by the Board to determine if the researcher was fulfilling the
benefit requirement of the Justice Principle. Redefining Justice to include the Human Development Approach, implementing the VEIA, and
having the Board complete the VEIA before certifying research will
begin to address the structural and institutional racial biases that lead
to exploitation.
A. Ending Exploitation: Human Development Approach

Although originally couched in terms of global justice, the time has
come to apply the Human Development Approach to medical research
conducted in the United States on populations that suffer the same
social and economic disadvantages as those in the developing world.
This Approach offers insightful guidance on how to prevent the exploitation of economically disadvantaged minority children participating in
medical research studies conducted in the United States.
1. Theory

The Human Development Approach is a means to combat the
“minimalist view” that “accepts the status quo in the host community
as the appropriate ‘normative baseline’ against which proposed research
initiatives are evaluated—meaning that the status quo is treated as the
threshold of a person’s moral entitlements in this particular sphere.”239
Because the minimalist is only worried about doing no harm (Nonmaleficence) and providing a benefit (Beneficence), then the status quo
allows him to avoid questions of distributive justice. The status quo
allows the minimalist to view harm as any additional damage greater
than the status quo caused to the research subject and a benefit as any
gain.
One example of the minimalist approach is the inclusion/fair opportunity theory that believes research is just if everyone is provided an
opportunity to participate, regardless of whether the research will further burden the most disadvantaged of the population or provide them
with a direct benefit. 240 The inclusion/fair opportunity theory champions leaving up to the discretion of the researchers and the host country to conclude what will benefit research subjects. However, this theory
leaves little room to determine what is a meaningful benefit for the
239. London, supra note 17, at 27.
240. See id. at 25 (“The debate about justice has become synonymous with the
question of who gets access to the fruits of successful research.”).
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research subject, because the power balance remains with the researcher
and host country, not the research subject. 241 Notwithstanding this
power imbalance, proponents of this theory believe that the host country can bargain for a host of benefits that are comparable or better than
benefits given in developed countries. 242 However, in reality, the research subject is dependent on the charity of the researcher and the
host country.
This minimalist approach also favors “justice as mutual advantage.” 243 Proponents of the minimalist theory believe that researchers
and research subjects receive a mutual advantage. Researchers obtain
subjects and research participants receive bargained-for benefits. Yet,
the Justice Principle is not about creating a mutual advantage; rather,
it proscribes the duty researchers owe to their research subjects. As
noted in the Belmont Report, the Justice Principle requires that researchers have a duty to assess whether potential research subjects and
the population from which they come will benefit from the research.244
London notes that this duty flows from contractual and citizenship
obligations. 245
Specifically, in developing countries, researchers contract with government officials to use their citizens for medical research studies.246
However, the governments of some developing countries are often the
cause of the poverty and poor health of their citizens. The failure to
take this into consideration, and the broader social and economic context in which the research takes place, eliminates the infomation necessary to determine whether the researcher is contracting with those
who have caused the social and economic disadvantages of the research
population. 247 “These failures can generate prior moral claims that the
community members have against their own authorities, and such
claims may constrain the range of cooperative or collaborative relationships in which researchers may permissibly engage.” 248 By contracting
with these governments, the researchers have become accomplices in
241. See id. at 26 (“[D]etails about the level and type of benefit require value
judgments that are best left to the discretion of those in the host community.”).
242. Id.
243. Id. at 25 (citation omitted).
244. Belmont Report, supra note 5, at 23,194.
245. London, supra note 17, at 30 (“[D]uties of rectification may attach to researchers who work for or are funded by entities that have contributed more
directly to the plight of developing world populations.”).
246. Id.
247. Id.
248. Id.
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the devastation of these populations. To rid themselves of complicity,
researchers have a special contractual duty to aid the populations they
are using for research. 249
Furthermore, as citizens of developed nations that have caused or
facilitated the lack of access to health care and medicine in developing
nations, the researchers have a duty to aid the populations they are
using for research. 250 London submits that “at the most general level
duties of rectification may attach to all citizens of democratic nations
whose policies and international activities have contributed to the plight of those in the developing world.” 251 Policies that have contributed
to the plight of those in the developing world, includes participation in
the Agreement on Trade-Related Aspects of Intellectual Property
Rights (TRIPS) agreement, which protects pharmaceutical companies’
intellectual property rights across the world. 252 Even though TRIPS
allows for countries to import or produce generic versions of some medicines in cases of national emergency, United States pharmaceutical companies have aggressively pressed for trade sanctions or instituted legal
action under TRIPS that have blocked legitimate efforts to provide
medicines to developing countries in cases of national emergencies, such
as the HIV/AIDS epidemic. 253
This citizenship duty requires researchers to limit the use of individuals from developing countries to instances where the medical research
studies will “expand the capacity of the host community’s basic social
structures [] to meet the distinctive health priorities of that community’s members . . . .” 254 Only then is it permissible to use a developing
nation’s scarce public resources for medical research studies. 255 Thus,
medical research is acceptable if it functions “as a part of a division of
labor in which the distinctive scientific and statistical methods of the
research enterprise target and investigate the means of filling the gaps
between the most important health needs in a community and the

249. Id.
250. Id.
251. Id. International activities that have contributed to the plight of individuals
in developing nations also includes what Thomas Pogge calls “international
resource privilege.” Id. This privilege is the ability to wrestle control away from
legitimate developing country governments as a means to enrich the privileged
few. Id.
252. Id. See also Cynthia Ho, Access to Medicine in the Global Economy:
International Agreements on Patent and Related Rights (Oxford
Univ. Press, 2011) (discussing TRIPS and its effects on access to medicine).
253. London, supra note 17, at 30.
254. Id. at 33.
255. Id.
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capacity of its social structures to meet them.” 256 To be just in developing countries, research “must directly and indirectly expand the capacity of the host community’s basic social structures either to meet the
distinctive health priorities of that community’s members or to meet
their basic health needs under distinctive social or environmental circumstances.” 257 If the country does not have an appropriate structure
available, then the researcher must work with community and international groups to create a structure. 258 The structure must be sustainable, and thus the research should serve as the anchor for which additional long-term aid can be provided. 259
Clearly, the injustices suffered by those in developing nations are
not the full responsibility of the researchers. However, by using the
citizens of these nations for their own benefits, researchers and their
institutions have a duty to provide the research subjects with a meaningful benefit. 260 The condition of providing sustainable social structures
to improve health outcomes in the host community is not an onerous
requirement.
This condition is easily fulfilled, for example, when developed
countries collaborate on research that targets a common problem.
When doing research in developing nations, it might be fulfilled
if researchers can find host communities in which the target of a
research program represents a health priority and where the resulting intervention could be implemented within the health structures of the host community. 261

Although couched in international terms, the Human Development
Approach can also apply to the United States’s domestic problems of
exploitation of economically disadvantaged children for the greater
good.
2. Human Development in the U.S.

In the United States, researchers have the same contractual and
citizenship obligations. In terms of contractual obligations, researchers
in the United States have a duty to ensure that they are not contracting
with those who have caused the social and economic disadvantages suffered by the potential research subjects. More specifically, researchers

256. Id.
257. Id.
258. Id. at 34.
259. Id. at 33.
260. Id.
261. Id. at 35.
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should not contract with those who have caused structural and institutional racial biases to prevent economically disadvantaged minority
children from accessing health care. For instance, researchers should
not have contracted with states to enroll foster children in HIV/AIDS
drug studies 262 because, as discussed in Section II.C. and in more detail
in subsection 1, states have failed to provide the children with adequate
health insurance that would provide them with access to health care.263
Furthermore, the states failed to test the children to ensure that they
suffered from HIV/AIDS, unnecessarily exposing the children to risk.264
The failures of the states to provide adequate health insurance and to
test the children for HIV/AIDS creates prior moral claims that the
children have against the states, which constrains the researchers’ ability to enter into a contract with the states. By contracting with the
states, the researchers have become accomplices in the devastation of
the children, which they can only rid themselves of by providing the
children with a benefit that will alleviate some of their underlying
problems. The researchers also have a citizenship duty.
The citizenship duty is based on researchers’ affiliation with institutions or hospitals that have erected insurmountable barriers to access
to health care for economically disadvantaged minority children. As
discussed in Section II.D., health care institutions have sued economically disadvantaged patients who qualify for charity care and denied
care to economically disadvantaged and minorities. 265 However, when
seeking subjects for their medical research studies these same institutions seek out the same economically disadvantaged minority children
they refused to treat. Denied access to health care, these economically
disadvantaged minority children are willing to participate in medical
research studies, even if access to health care is offered for a short duration of time.
By denying economically disadvantaged minority children access to
health care, these institutions are creating a vicious cycle that will not
be fixed until these institutions are required to provide a benefit to the
population of economically disadvantaged minority children that will
alleviate some of their underlying problems.
3. Applying the Approach to U.S. Research

Some may argue that the HIV/AIDS drug studies did not violate
the Justice Principle because although the children suffered serious side
effects including death, the children were going to die anyway from
262. Solomon, supra note 130.
263. See supra note 189 (listing cases that involved challenges to the state for
failure to access health care for child Medicaid recipients).
264. Yearby, supra note 15, at 26, 32.
265. See supra Part II.D.
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HIV/AIDS, so there was no additional damage. Furthermore, the children gained a benefit because they were granted access to health care
and investigational drugs during the study. This is the minimalist approach. 266
The problem with researchers that use the minimalist approach is
they only use morally relevant information regarding the social and
economic context of the subjects 267 in a manner that benefits their research. The reason that the research subjects are so attractive is because
of their social and economic disadvantage. Thus, researchers capitalize
on this advantage and use it as an entitlement to further exploit the
vulnerable, using fair opportunity as a guise. However, when applying
the Human Development Approach to the HIV/AIDS drug trials it is
clear that the Justice Principle is not entitlement to research, rather it
imposes specific requirements on researchers or their sponsoring agencies. 268
Applying this Approach to the above-mentioned HIV drug study,
it is clear that the researchers should never have contacted the States
to enroll economically disadvantaged minority children in foster care to
participate in the studies because at the time of the study it was not
clear that the population was affected by the disease. More specifically,
it was not clear that any of the children who participated in the studies
even suffered from HIV/AIDS. Thus, researchers had a duty not to use
foster children.
This duty arises from two relationships. First, the researchers were
often contracting with states that had prevented economically disadvantaged children from accessing health care. Because researchers were
contracting with States that had chosen to limit economically disadvantaged children’s access to medical care through under-funding of Medicaid, the researchers had a duty to alleviate some of the underlying
problems faced by economically disadvantaged children, such as lack of
access to medical treatment. Second, the researchers were citizens affiliated with institutions that denied access to care to economically disadvantaged minority children. If researchers decided to use economically
disadvantaged minority children as subjects they had a duty to provide
a benefit to the vulnerable population from which the subjects originate
that alleviated some of the populations’ underlying problems, such lack
of access to health care.
To measure whether the benefit will alleviate some of the populations’ underlying problems, I suggest that researchers be required to
266. London, supra note 17, at 26 (“[T]he minimalist view frames the fundamental problem of justice in international research in terms of two salient
variables: the needs and vulnerabilities of the host population, and the capacity of research to benefit and to burden.”).
267. Id. at 28.
268. Id. at 34−35.
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use the VEIA tool. The VEIA is based in part on Health Equity Impact
Assessment tools. 269
B. Measuring Justice: Vulnerability and Equity Impact Assessment Tool

In 1970, the United States became the first country to require impact assessments to attempt to predict the impact of policies on environmental health. 270 Since 1999, many countries, such as Germany,
Switzerland, the Netherlands, Australia, New Zealand, Canada, and the
United States, have adopted this tool for use in the health policy field
to avoid or minimize negative impacts on health. 271 Impact assessment
tools put the burden on those completing the tool to show that their
actions will not negatively impact the health of the population.
The Health Impact Assessment (HIA) is “a combination of procedures, methods and tools by which a policy, programme or project may
be judged as to its potential effects on the health of a population, and
the distribution of those effects within the population.” 272 There are two
main functions of the HIA: 1) to support policy making when choosing
between options; and 2) to predict the future consequences of implementing different policy options. 273 There are six key stages in using a
HIA: “screening, scoping, data collection, impact appraisal, reporting/
recommendations, and monitoring/evaluation.” 274 By using the HIA,
policymakers can adopt the most beneficial policy for the population’s
health. Attaining equity in health can be one of the priorities in completing a HIA. However, equity is not the main focus of the HIA.275
Although the HIA can determine if the policy will have different impacts on different social groups, the process does not provide information concerning whether these differential impacts are a result of unfair
and biased policies. 276
Consequently, the Health Equity Impact Assessment (HEIA) tool
was created to ensure that assessments about a policy’s impact would
269. Haber, supra note 18.
270. National Environmental Policy Act of 1969, 42 U.S.C. § 4321 (2012).
271. Eur. Observatory on Health Sys. & Policies, The Effectiveness
of Health Impact Assessment: Scope and Limitations of Supporting Decision-Making in Europe 4–5, 17 (Mathias Wismar et. al. eds., 2007).
272. Id. at 3. (citation omitted).
273. Id.
274. Susan L. Povall et al., Health Equity Impact Assessment, 29 Health Promotion Int’l 621, 622 (2013).
275. Id. at 629.
276. Id. at 622. This study found that even when equity was a central theme of
the HIA, the impact analysis did not go beyond identifying vulnerable populations and the differential effects of the policy on these populations. Id. at
629.

1218

Case Western Reserve Law Review·Volume 67·Issue 4·2017
Exploitation in Medial Research

include an evaluation of fairness and equity as well as root causes of
inequities. 277 The HEIA identifies “deeply rooted disparities in income,
wealth, knowledge, social status and connections” as “[f]undamental
causes” of health inequity. 278 The World Health Organization’s Commission on Social Determinants of Health has recommended the use of
the HEIA in all global, national, and local policy making. 279 New Zealand, Australia, Canada, the United Kingdom, the United States, and
other countries currently use the HEIA. 280 There are five steps involved
in completing a HEIA:
1. Screening
Determine if the initiative requires a HEIA. If the initiative has
the potential to impact the health of vulnerable or disadvantaged
groups, HEIA is applicable. It is desirable that all initiatives be
screened.
2. Scoping
Identify affected populations or groups and predict key impacts
(positive or negative) on those groups. Consider a wide range of
vulnerable or disadvantaged groups to avoid overlooking unexpected or unintended consequences of an initiative.
3. Impact Assessment
Use available data/evidence to prospectively assess the impacts
on vulnerable or disadvantaged groups in relation to the broader
target population. It is both useful and important to consider a
broader range of evidence including consultation findings and grey
literature (including project or program reports, informal practice
guidelines, recommended or promising practices). These sources
of evidence should be weighed based on their strength and quality.
Where there is very limited data/evidence available, note the lack
of evidence in the assessment or, where possible, implement other
strategies to gather evidence. Strategies could include conducting
surveys, focus groups, or consultation with experts or members of
the affected groups where time permits.
4. Mitigation Strategy
Develop evidence-based recommendations to minimize or eliminate negative impacts and maximize positive impacts on vulnerable or disadvantaged groups. These recommendations comprise
277. Id. at 629.
278. Id. at 631−32.
279. Id. at 631.
280. Ontario Ministry of Health and Long-term Care, Health Equity
Impact Assessment (HEIA) Workbook 8 n.1 (2012) [hereinafter HEIA
Workbook].
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your mitigation strategy. Uptake of these recommendations in the
roll out of the initiative will help to ensure that the initiative
contributes to equity and does not perpetuate or widen existing
health disparities. Where possible, recommendations should be
informed by diverse members of the affected communities.
5. Monitoring and Evaluation
Determine how the rollout of the initiative will be monitored to
determine its impacts on vulnerable or disadvantaged groups in
comparison to other subpopulations or the broader target population. The resulting data will enhance the overall evidence base
for equity-based interventions and can be fed back into the planning, policy or program development process. 281

Once these steps have been completed, the organization must decide whether or not to implement the policy.
A Racial Equity Impact Assessment (REIA) tool has also been
created to identify the impacts of policies on racial and ethnic groups.282
Governments in Iowa, Connecticut, Seattle, and the United Kingdom
have adopted the REIA. 283 Although the primary focus of the HEIA
and REIA are to reduce health inequities, I believe that with some
modification these tools can be used to create a VEIA to determine
whether economically disadvantaged minority children should participate in medical research studies.
Specifically, the VEIA should be used to assess whether a proposed
medical research study will provide a benefit to economically disadvantaged minority children that will alleviate some of the underlying problems that prevent them from accessing health care. While in this Article, I focus on how the VEIA can be used to protect economically
disadvantaged minority children, I believe that the VEIA can be used
to protect all vulnerable populations. 284

281. Id. at 14−15. The HEIA Workbook lists “Dissemination” as a fifth step,
which “involves sharing results and recommendations for addressing equity.
Dissemination is a cyclical process, interacting with step four (monitoring).”
Id. at 15. Here, the screening process, where it is decided whether the HEIA
applies, is treated as step one.
282. Terry Keleher, Race Forward, An Introduction to Racial Equity Assessment
Tools: Governing for Racial Equality 29 (Mar. 2014) (presentation on file
with author).
283. Id.
284. The VEIA can also be used to measure whether researchers are complying
with informed consent. Ruqaiijah A. Yearby, Involuntary Consent: Conditioning Access to Health Care on Participation in Clinical Trials, 44 J.L.
Med. & Ethics 445−61 (2016); Yearby, supra note 15.
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1. The VEIA

First, the researcher must screen the research proposal to identify
the purpose of the research, what the research seeks to accomplish, and
whether the research will impact the health and well-being of economically disadvantaged minority children. Additionally, the researcher
must discuss whether the research is a priority for economically disadvantaged minority children. This review coincides with the current requirement of showing that the research will add to generalizable scientific knowledge. 285
In order, to answer this question, the researcher must engage economically disadvantaged minority children or someone who represents
their interests, such as child advocates from non-governmental agencies
like Marian Wright Edelman, the President and Founder of the
Children’s Defense Fund. 286 This screening dovetails with procedures
used by researchers when they conduct international research to ensure
that the research is culturally competent. 287 Once this introspective
review, or screening, has occurred and is noted in the research proposal,
then the researcher must complete the scoping, impact assessment, and
mitigation strategy steps.
To complete the scoping step, the researcher must answer the following questions:
1. What populations are most affected by the condition being
studied?
2. If economically disadvantaged minority children are most affected by the condition, are there other less vulnerable populations
that can be used for the research?
3. Will the research alleviate some of the populations’ underlying
problems?
4. Will the population from which the subjects originate gain access to the treatment after the study is concluded?
If economically disadvantaged minority children are most affected
by the condition, then the researcher must assess whether the impacts
on this population will be negative or positive. To complete the impact
assessment step, a researcher must use all available data, such as empirical research studies. If there is limited data available, then the researcher should collect data by “conducting surveys, focus groups, or

285. The OHRP Guidebook concerning medical research adds minorities to the
list of vulnerable populations. OHRP, Institutional Review Board
Guidebook (1993) (on file with the author).
286. Children’s Defense Fund, Marian Wright Edelman, ChildrensDefense
.Org (2017), http://www.childrensdefense.org/about/leadership/marianwright-edelman/ [http://perma.cc/7QTP-E6LE].
287. Id.
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consultation with experts or members of the affected groups.” 288 The
evidence should be used to answer the following questions:
1. Disparities:
a. Are there race, class, and/or age disparities in the number
of people who suffer the condition or survive from the condition?
b. Which racial/ethnic groups are currently most advantaged
and most disadvantaged by the issues this research seeks to
address?
c. Which socioeconomic groups are currently most advantaged and most disadvantaged by the issues this research
seeks to address?
d. Which age groups are currently most advantaged and most
disadvantaged by the issues this research seeks to address?
e. How are the advantaged and disadvantaged groups affected
differently?
f. What quantitative and qualitative evidence of inequality
exists?
g. What evidence is missing or needed?
h. Will the research exacerbate these disparities? 289
2. Burdens:
a. What are the barriers to accessing health care for economically disadvantaged minority children who are potential
research subjects?
b. Will participation in medical research studies increase these
barriers?
c. Will participation in medical research studies alleviate
these barriers?
d. What are the root causes of the barriers to accessing health
care, such as structural and institutional racial biases?
e. Will the research address these root causes?
3. Adverse Impacts:
a. What potential adverse impacts or unintended consequences could result from participation in this research beyond
the burdens?
b. Will the impacts or unintended consequences further burden economically disadvantaged minority children?
c. How could adverse impacts be prevented or minimized?
4. Equitable Impacts:
a. What are positive impacts on the populations underlying
problems, such as increased access to health?
288. HEIA Workbook, supra note 280, at 14–15.
289. See Keleher, supra note 282, at 30 (providing sample questions to assist in
assessing the impact of proposed actions on various racial groups).

1222

Case Western Reserve Law Review·Volume 67·Issue 4·2017
Exploitation in Medial Research

b.
c.
d.
e.

Which racial/ethnic groups could benefit?
Which socioeconomic groups could benefit?
Which age groups could benefit?
Are there further ways to alleviate some of the populations’
underlying problems? 290
Using the answers from these questions, the researcher must provide an evidence-based determination of whether economically disadvantaged minority children should be used as research subjects because
the research will alleviate some of the populations’ underlying problems,
such as access to health care.
If the researcher decides to use economically disadvantaged minority children as research subjects even though there is a possibility of
increasing barriers to health care, the researcher must develop a mitigation strategy that will alleviate another underlying problem of economically disadvantaged minority children such as access to essential
goods such as food, education, and housing. If there is a mitigation
strategy, the researcher must monitor the actual strategy and show that
the strategy has alleviated another underlying problem.
2. Applying the VEIA

If researchers are required to apply the VEIA, many research studies that exploited economically minority children in violation of the
Justice Principle would never have been funded.
For example, if the researchers discussed in Section II.B., who used
African American and Latino foster children to test HIV/AIDS drugs,
had been required to complete a VEIA, it would have shown the research violated the Justice Principle.
First, the researchers would have been required to screen the research to identify the purpose of the research, what the research sought
to accomplish, and whether the research had the potential to affect
economically disadvantaged minority children. 291
Clearly, the screening would have shown that the medical research
study had the potential to impact economically disadvantaged minority
children if they were used as subjects, and it was unclear why healthy
children had to be used to test HIV/AIDS drugs. Furthermore, there
was no evidence that this research was a priority to healthy economically disadvantaged minority children in foster care. If the researchers were able to show that it was a health priority, the research would
still be prohibited under the scoping step. There was no evidence that
at the time of the research economically African American and Latino
children were the group most affected by HIV/AIDS. Therefore, other
children should have been used. Moreover, the impact assessment of the
disparities, the burdens, the adverse impacts, and the equitable impacts
290. Id.
291. See supra Section III.B.1.
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would have shown that economically disadvantaged minority children
were negatively impacted with little to no benefit. Specifically, economically disadvantaged minority children were not the group most affected by HIV/AIDS (disparities) and the children had barriers to accessing health care because they used Medicaid (burdens). The research did
not address these barriers. In fact, the research increased these barriers
by making healthy children sick, who had limited access to health care
(adverse impacts) and did not provide any positive impacts in terms of
treatment or increasing access to health care (equitable impacts). Thus,
the children should not have participated in the medical research studies.
This is just one example of how using the VEIA to measure the
redefined Justice Principle will protect economically disadvantaged
minority children from being exploited. However, the incorporation of
the Human Development Approach in the Justice Principle and implementation of the VEIA will not put an end to exploitation without
changing the current regulatory structure governing medical research
studies involving children.
C. A New Regulatory Structure

In the past OHRP and individual IRBs have been responsible for
preventing economically disadvantaged minority children from being
exploited in medical research studies. 292 The examples discussed in
Section II.B. suggest that neither OHRP nor individual IRBs have been
successful in accomplishing this task. Thus, I suggest the creation of a
U.S. Human Research Protection Review Board for Children using the
authority granted by the Common Rule to review medical research
studies otherwise unapprovable. 293
The Board for Children would be in charge of determining whether
domestic medical research studies involving children were ethical based
upon the redefined Justice Principle. 294 Before a medical research study
is conducted, the Board of Children would be required to review the
research proposal, including the VEIA, to evaluate whether the research
exploits economically disadvantaged minority children for medical research studies in violation of the redefined Justice Principle.
To accomplish this task for research governed by the Common
Rule, the Board for Children needs to have adequate community participation and specific requirements for the approval of research. The
Board for Children must include at least two members of each group
identified as a vulnerable population in the Common Rule. The Board
for Children must also consist of at least two physicians that conduct
292. 45 C.F.R. § 46.103(b)(1) (2015); OHRP Memorandum, supra note 81.
293. 45 C.F.R. § 46.407 (2015).
294. In addition, the Board can review issues regarding Autonomy and Beneficence.
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research. However, these physicians cannot be from institutions that
deny children access to health care or have been cited for violations by
the OHRP. Finally, the Board for Children should include three bioethicists, two child advocacy members, and two government employees.
The Board must review the VEIA for all medical research studies
using children governed by the Common Rule to ensure the studies
comply with the redefined Justice Principle. This review must occur
before the researcher submits the proposal for funding. The Board
would be responsible for reviewing the VEIA for each research proposal
to make sure that the study was not exploiting economically disadvantaged minority children for medical research studies. 295 If the VEIA
shows that there is no exploitation and that the study was necessary
and safe, then the Board should approve the study and post the VEIA
on clinicaltrials.gov.
The creation of the Board is just the beginning of the structural
changes that need to be made to the regulation of medical research
studies using children. Additionally, new penalties need to be imposed
if a researcher and/or institution violates the Justice Principle. Currently, OHRP just issues letters and suspends researchers from federally
funded research. Violations of the Justice Principle should also result
in fines, loss of federal funding, and denial of drug approval. Researchers
that violate the requirements should also face criminal fines. 296 Furthermore, victims of research conducted in violation of the Justice Principles should be granted a private right of action against the institution
and the researcher.

Conclusion
Professor Patricia King, one of the drafters of the Belmont Report,
noted, “[d]espite common recognition that ‘the Tuskegee Study is America’s metaphor for racism in medical research,’ there has been inadequate attention paid to race, either in the sense of negative and differential treatment or in terms of pervasive scientific racism, in the construction of bioethics in the United States.” 297 Specifically, neither researchers nor those who regulate medical research studies take into account structural and institutional racial biases that prevent vulnerable
295. The Board would also be responsible for ensuring that the researchers are
complying with the other requirement of Justice, which is that members of
the vulnerable population participating in the study will directly benefit from
the study.
296. See, e.g., Richardson, supra note 86, at 127 (discussing the potential deterrent effect of criminal punishment on researchers).
297. Patricia A. King, Reflections on Race and Bioethics in the United States, 14
Health Matrix 149, 150 (2004) (quoting Susan M. Reverby, Introduction
to Tuskegee’s Truths, supra note 14, at 3).
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populations, such as economically disadvantaged minority children,
from accessing health care, making them vulnerable to exploitation in
medical research studies that promise access to health care. Thus,
economically disadvantaged minority children continue to be exploited
in medical research studies that do not provide a benefit to the population from which they originated.
As Carol Levine notes, “[t]here [has been] no resolution of the conflict between American society’s failure to provide basic healthcare and
HIV/AIDS prevention programs to poor communities of color—a
matter of social justice—and the potential coerciveness of using research
participation as an entry into the health care system.” 298 Hence, the
time has come to put an end to this exploitation by enforcing the Justice Principle to prevent the use of all children, but especially economically disadvantaged minority children, in medical research studies for
which they will not receive a benefit. This will only happen if the Justice
Principle stands for more than inclusion. The Justice Principle must be
a measurable standard that ensures fairness, equity, and the right of
children to reach their full health potential without interference. Otherwise, children will continue to be sacrificed for the benefit of an unworthy society.

298. Levine, supra note 1, at 121.
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